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Integrated delivery systems increasingly seek to identify high-risk patient sub-groups where 
effective interventions can reduce costs. Most predictive models for utilization incorporate un-
modifiable factors such as health status, clinical severity, and demographics. In contrast, patient 
activation – the beliefs, knowledge, and skils that support self-management behavior – is 
modifiable. We explore whether activation, measured by the Patient Activation Measure (PAM), 
predicts utilization and whether motivational interviewing (MI) improves patient activation.  
We analyzed a retrospective cohort of high-utilizing Medicaid patients enroled in a MI program 
who completed PAM surveys between 2009 and 2011. We used proportional hazard models to 
predict time to emergency department (ED) visits and hospitalizations using PAM, clinical risk, 
and health status as main predictors. We used generalized estimating equations to model PAM 
score change based on type of MI intervention. We explored interactions of demographics and 
patient engagement with key predictors. Our eligible population included 1,676 patients from 
four medical centers within Kaiser Permanente Northern California (KPNC), a large integrated 
health care delivery organization. Our study population comprised 1,041 patients (62 percent) 
who completed ≥1 PAM surveys.  
While the relationship between activation with ED visits was insignificant in fuly adjusted 
models, lower activation was associated with higher ED visit risk (HR: 1.40, p<0.01) for patients 
lacking stable primary care physician relationships. The association of activation with 
hospitalization was insignificant after adjusting for clinical risk. For the 915 patients with 2+ 
PAM surveys, the overal MI intervention was associated with an unadjusted first PAM-to-last 
PAM mean score improvement of a clinicaly meaningful 4.1-points (p<0.01). Lower activation 
patients received the most interventions (PAM Level 1: 2.5/month; Level 2: 1.9/month; Level 3: 
1.7/month; Level 4: 1.5/month; χ2 p<0.01) and improved the most (adjusted PAM score change 
 ii 
for Level 1 versus Level 4: 12.7 points; Level 2 versus Level 4: 11.9; Level 3 versus Level 4: 8.6; 
al p<0.01). 
We infer that PAM may be more useful for targeting interventions for behavior sensitive 
outcomes such as ED visits. MI seems to be effective in improving activation in this complex 
patient population.  
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Chapter	  1:	  Introduction	  
The Problem 
This project is motivated by a three-part problem facing integrated Health Maintenance 
Organizations (HMOs), Accountable Care Organizations (ACOs), and other provider 
organizations responsible for the total cost of care for individuals:  
1. Health care costs are concentrated among people with multiple chronic conditions. The 
concentration of expenditures has long been a fundamental characteristic of health care 
markets. Based on the Medical Expenditure Panel Survey (MEPS), 1% of the population 
accounted for 22% of 2010 health care costs, and 5% of the United States population 
accounted for 50% of costs.1  About one-third of this 5% were in the top 5% group in 
both 2009 and 2010.1 An analysis of Medicare’s 2010 acute-care expenditures found that 
10% of patients account for 70% of the total costs.2 “Failures of care coordination” 
where patients “fal through the slats in fragmented care” account for between $25 and 45 
bilion in 2011 of waste, and between 1.0% and 1.7% of total health care costs.3 Failure 
of care coordination is an especialy important problem for people with chronic 
conditions, particularly multiple or complex chronic conditions. Two-thirds of total 
healthcare spending is for people with multiple chronic conditions, and 79% of Medicare 
spending is for people with five or more chronic conditions.4  
2. We don’t have a solution, certainly not a cost-effective one.  The chronic care and 
medical home models provide clear roadmaps for action for patients with high medical 
needs. These models envision continuous support by a multi-disciplinary care team 
folowing evidence-based guidelines with strong decision support, providing support for 
patient self-management, and coordinating with community resources to provide social 
support.5-7 Care providers have designed innovative solutions based on these models that 
 2 
make for excelent case studies and best practice summaries,8,9 but they have not yet fine-
tuned these practices in a way that reduces total healthcare costs, or covers the 
administrative costs of the programs. A comprehensive evaluation of Medicare's six 
major disease management and care coordination demonstration programs found litle or 
no effect on hospital admissions or net Medicare expenditures.10 
3. Accountable providers and insurance companies are under significant pressure to solve 
this problem cost-effectively. Although many of these forces were always in place, 
changes from the Affordable Care Act (ACA) and major purchaser policies have 
intensified the importance of a solution. Medicare has reduced payments to Advantage 
plans eliminating their long-time overpayment, the state and federal insurance exchanges 
create an intensely price competitive market for individual insurance, and major 
purchasers are moving toward risk adjustment which makes risk avoidance strategies 
increasingly difficult.  
In developing cost-effective care management strategies for high-cost patients, healthcare 
providers might face important cultural obstacles: are the shared beliefs of healthcare 
professionals about high-cost patients helping them to identify the best solutions or are they 
geting in the way? 
Stereotypes about high-cost patients 
Although the word stereotype is commonly defined as having an over simplified or inaccurate 
view of a person or group, social psychologists define the term without this negative connotation 
as “the typical picture that comes to mind when thinking about a particular social group” or, more 
simply, “shared beliefs about the group.”11 Three principles guide social psychologist’s thinking 
about stereotypes:12 
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1. Stereotypes are aids to explanation. “We cannot have an impression of a group unless we 
can tel the difference between that group and some other group. Categorization is the 
cognitive process by which we detect those differences and similarities.” 
2. Stereotypes are energy-saving devices. “Treating people as group members saves energy 
because it means that we can ignore al the diverse and detailed information that is 
associated with individuals.” 
3. Stereotypes are shared group beliefs. “They are shared by members of the group not just 
through the coincidence of common experience or the existence of shared knowledge 
within society, but because the members of groups act to coordinate their behavior.” 
Stereotypes are “a functional means for simplifying a complex environment.”11 As a manager of a 
care coordination team, these three characteristics would be helpful for reliably delivering care if 
our stereotypes about high-cost populations were correct.  However, our lack of success in 
delivering cost-effective interventions suggests that we need to chalenge our stereotypes. 
The words we use represent the atitudes, or prejudices, we have towards a group.11 In 
healthcare, we use a variety of words to categorize problematic patients that probably represent 
our atitudes and beliefs: non-compliers, non-adherers, non-responders, no-shows, or FTKAs 
(patients who fail to keep appointments). Understandably, as a caring profession trained to heal 
ilness, the words articulate the behavioral gap between what patients do and what healthcare 
professionals know they need to do. Although these atitudes occasionaly lead to discriminatory 
action, like discharging or withholding services from “noncompliant” patients, usualy healthcare 
providers, particularly those in integrated systems responsible for the ful cost of care, seek to 
identify patients with clinical barriers, and find creative ways to overcome them. Innovative 
providers are also seeking to identify and address non-medical barriers such as literacy, access to 
food, transportation, adequate housing, and supportive environments.8 However, viewing high-
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cost patients through the lens of their failures, deficits, and barriers might not be the best way to 
engage patients in taking care of their own health. 
Moving from “what’s the matter” to “what matters to you” 
Whether focused on medical or non-medical needs and barriers, healthcare providers are taking 
the approach of diagnosing and treating diseases and problems. At the Institute for Healthcare 
Improvement’s 2013 National Forum, Maureen Bisognano chalenged atendees to flip 
healthcare, as some educators have flipped the purpose of the classroom, by changing our framing 
from “what’s the mater” with the patient to “what maters” to the person we are serving.13 
Although few might argue with this recommendation in concept, it chalenges the shared beliefs 
(stereotypes) among healthcare professionals about what patients realy need.  
We know that self-care behaviors are crucial for living wel with chronic disease, but the best 
strategies for achieving improvements in self-management are unclear. For example, studies of 
patients with heart failure show equivocal or negative evidence of beter outcomes for patient 
self-management support interventions compared to standard education.14,15  
Cost effectively engaging patients in self-management requires investigation of the best ways to 
match the care delivery systems actions to what maters to patients; and, to identify whether 
patients need our help in achieving their goals, or whether they have the self-management 
motivation and skils to reach their goals with litle assistance. 
Motivational Interviewing and the Patient Activation Measure 
Motivational interviewing (MI) is a promising approach for improving self-care behaviors and 
“acknowledges the patient’s expertise into his or her own problems and empowers the patient to 
develop his or her own motivation.”16 MI is a colaborative process for resolving a person’s 
ambivalence about change and choosing actions that motivate a person, as opposed to a typical 
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clinical encounter where a patient’s problems are diagnosed, and they are prescribed actions and 
treatments. Recent meta-analyses found that motivational interviewing (including brief 
intervention) improved self-efficacy, engagement, health behaviors, medication adherence, 
clinical markers, and quality of life.16-18 However, MI’s cost-effectiveness is less clear.19,20 
Patient activation as measured by the Patient Activation Measure (PAM) may be a practical way 
to customize an MI intervention to the patients who would benefit the most.21,22 The original 
study developing the PAM measure defined activated patients as those who: 
…believe [they] have important roles to play in self-managing care, colaborating with 
providers, and maintaining their health. They know how to manage their condition and 
maintain functioning and prevent health declines; and they have the skils and behavioral 
repertoire to manage their condition, colaborate with their health providers, maintain 
their health functioning, and access appropriate and high-quality care.23  
Tailored MI interventions based on the level of patient activation may have the potential for cost-
effectively improving behaviors and outcomes. Patients at lower levels of activation may receive 
higher intensity interventions aimed at building a belief that what they do maters for their health, 
and patients at higher levels of activation may receive lower intensity, and less expensive 
interventions, aimed at assisting them in staying on track during times of stress. 
Research Question and Study Objectives 
This project aims to help healthcare providers identify categories of high-cost patients who would 
benefit the most from self-management support interventions. Our broader question is whether 
the PAM can assist healthcare providers to target MI interventions to improve patient-centered 
outcomes and decrease costs. Because we were not able to design and implement a randomized 
experiment of this approach, we focused our research on an existing cohort of high-cost Medicaid 
patients who completed PAM surveys and received MI interventions. For this group, we asked 
the question: 
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Does the level of a patient’s activation independently predict future utilization, and, if so, do 
motivational interviewing interventions improve patient activation? 
We pursued the folowing research objectives: 
1. Develop a predictive model for risk of future hospitalizations for groups of high-utilizing 
patients using clinical risk, prior utilization, self-reported health status, and patient 
activation as the key predictor variables (see Model A in Figure 1). This predictive 
model examined the extent to which patient activation modifies the relationships between 
clinical risk, health status, and future utilization. Development of this model included the 
exploration of the interaction of patient activation with demographic and engagement 
factors that could confound or modify the effect of patient activation on utilization. 
2. Develop a predictive model for future emergency department (ED) visits (see Model A in 
Figure 1). We anticipated that this model would include diferent factors than the 
hospitalization predictive model because the causes of ED visits may be different. 
Developing this model also included the exploration of confounding and modification of 
effects by demographic and engagement variables. 
3. Develop a longitudinal model to predict changes in patient activation based on the 
frequency and types of interventions by care managers trained in motivational 
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Manuscript	  I:	  Predicting	  hospitalizations	  using	  the	  Patient	  Activation	  
Measure	  
Importance: Integrated delivery systems increasingly seek to intervene effectively with patients 
at high hospitalization risk.  Most predictive models use unmodifiable factors such as health 
status, clinical severity, and demographics. Measurement of patient activation – the beliefs, 
skils, and knowledge for self-management – could identify high-risk patients who would benefit 
most from interventions. 
Objective: To estimate the predictive value of the Patient Activation Measure (PAM) on future 
hospitalization among high-risk Medicaid patients.  
Design: Retrospective cohort study from December 2009 through December 2011. 
Setting: Four medical centers within Kaiser Permanente Northern California (KPNC), a large 
integrated healthcare delivery organization.  
Participants: Our eligible population included high-risk Medicaid patients aged 18-62 who had 
at least 10 months of KPNC membership, lived at home, and were enroled in a care management 
program. High risk was defined as 2-8 emergency department (ED) visits or hospitalizations in 
the prior year or Diagnosis Cost Group (DxCG) score of >= 3. From this eligible population, 
1,041 of 1,676 (62%) patients completed a PAM survey and are the subject of this analysis.  
Main Outcome Measure: Number and time to first hospitalization. 
Results: Participants were typical of non-elderly, high-cost California Medicaid patients: mean 
age, 38 years; 20% Hispanic; 45% African-American; DxCG mean score, 4.6; 55% obese or 
morbidly obese; 38% disabled. There were 532 hospitalizations and 1548 person-years at risk 
during folow-up for an event rate of 0.34 hospitalizations per person-year. In fuly adjusted 
models, hospitalization risk was explained best by health status, clinical factors, prior utilization 
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and engagement factors. Although not statisticaly significant, lower activation was associated 
with higher hospitalization risk among members with significant support systems (PAM Level 1, 
2, or 3 versus PAM Level 4 HR=1.57, p=0.07), and was associated with lower hospitalization risk 
among patients with some or no support system (PAM Level 1, 2, or 3 versus PAM Level 4 
HR=0.78, p=0.11).  
Conclusions and Relevance: In a high-risk Medicaid population, PAM had a weak and 
inconsistent relationship with higher hospitalization risk. These findings suggest that patient 
activation might not be strongly associated with hospitalization, an event that may be less 
sensitive in the short term to patient behavior.  
Introduction 
The concentration of expenditures is a fundamental characteristic of healthcare markets. Based 
on the Medical Expenditure Panel Survey (MEPS), 1% of the United States population accounted 
for 22% of healthcare costs in 2010, and 5% accounted for 50% of costs.1 About one-third of this 
5% population were also in the top 5% group in 2009.1 Healthcare managers make substantial 
effort to find ways to reduce costs in these highest risk patient populations. 
A substantial portion of healthcare expenditures may be preventable.3 A 2011 National 
Healthcare Quality Report estimated that the nation spent $26 bilion in 208 on potentialy 
avoidable hospitalizations.24 Other research has found that up to one-fifth of hospitalizations for 
diabetic seniors are preventable.25 Prior studies have found that clinical risk,26-30 self-reported 
health status,31,32 and demographic factors (race, socioeconomic status, insurance status)1,25,33-35 
are correlated with high or preventable utilization. Identifying these unmodifiable risk factors, 
however, does not help to inform the design of interventions to reduce healthcare utilization. 
Indeed, a comprehensive evaluation of Medicare's six major disease management and care 
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coordination demonstration programs found litle or no effect on hospital admissions or net 
Medicare expenditures.10 
Measuring patient activation is a potentialy innovative approach for guiding interventions to 
reduce future utilization.22 Patient activation is defined as a patient’s beliefs, knowledge, and 
skils for engaging in self-management behavior, and has been standardized through the 13-item 
Patient Activation Measure (PAM) (Appendix Table 14).36 While there is modest evidence that 
the PAM predicts future utilization controling for clinical risk, health status, and demographic 
factors,37-40 this relationship has not been studied within the high-risk, non-elderly Medicaid 
population that represents one of the major sources of our nation’s health expenditures. We tested 
the hypothesis that PAM scores predict hospitalization in this high-risk population after 




We conducted a retrospective cohort analysis of high-risk Medicaid patients enroled in a care 
management program implemented within an integrated health system. The program included 
assessment of patient activation using PAM surveys. Members were eligible if they were current 
Kaiser Permanente Northern California (KPNC) Medicaid members and: 
1. Had at least 10 months of Medicaid membership, and were not a Medicare member; 
2. Were ages 18 through 62; 
3. Had two to eight ED visits or hospitalizations (excluding maternity) in the past twelve 
months or Diagnosis Cost Group (DxCG)41 prospective score of greater than 3 (4 for the 
first two enrolment groups); and, 
4. Were not a resident of a skiled nursing facility or hospice. 
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Seting and Participants 
KPNC is a nonprofit, integrated healthcare delivery system providing comprehensive medical 
care to a diverse population of approximately 3.4 milion members. Distribution of patient 
demographic and socioeconomic factors is similar to that of the area population, except at the 
extremes of the income distribution.42 Al healthcare utilization is recorded within a 
comprehensive electronic medical record (EMR). 
Our study period begins at the point of completion of the first PAM survey, as early as December 
2009, and ends at the time of the patient's death or December 31, 2011, the end of the care 
management program. We did not track utilization beyond December 2011 because the intensity 
of interventions was a key covariate that ended at that time. 
Our study period is the second phase of the care management program that began 22 months 
earlier. Care managers at four geographicaly defined service areas received lists of eligible 
Medicaid members in February 2008, August 2008, December 2008, June 2009, and December 
2009. Care managers enroled members in the program and completed a baseline patient 
assessment. Each service area had a dedicated team comprising one registered nurse, two 
licensed vocational nurses, and one licensed clinical social worker. Beginning in December 
2009, al care managers were trained in motivational interviewing and PAM administration. We 
considered members to be "PAM eligible" if they met the folowing criteria: 
1. Coded as "enroled" as of or at any time after December 1, 2009; or, 
2. Had >=1 intervention or atempted contact after December 1, 2009. 
Care managers were instructed to atempt a PAM survey and conduct interventions at least every 
three months; however, this practice varied. As part of a quality improvement project, care 
managers administered the PAM by phone, occasionaly in person, and by mail before any care 
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management intervention. Many care managers folowed up with members after a hospitalization 
or ED visit. Members received a $10 gift card for completing their first PAM survey.  
Sources of Analytic Variables 
We obtained age, gender, date of death, membership status, and home zip code from KPNC 
membership files; and obtained race/ethnicity, spoken language, smoking status, disability, and 
body mass index (BMI) from the EMR. Chronic conditions (e.g. hypertension, diabetes, asthma, 
heart failure, and depression) were identified using KPNC’s population care registry archives, 
which are updated quarterly. For socioeconomic status (SES), we obtained zip code-level poverty 
rate, median household income, high school graduation rate, and colege graduation rate from the 
United States Census Bureau’s 2007-2011 American Community Survey (ACS). We created a 
binary pregnancy variable if a member had any maternity hospital encounters from September 
2009 through June 2012. 
When atempting to enrol members, care managers asked about working status, informal (non-
health care provider) support system (“none”, “some”, or “significant”), and substance use; or, 
care managers assessed these three variables from a chart review. Care managers also 
administered a six-item intake questionnaire (Appendix Table 16) on experience of care and 
health status (with wording very similar to the first question on the SF-36 survey, with identical 
response categories).43  
We created variables for the number of unique case management intervention days six months 
and twelve months before each analysis interval (see Appendix Table 20 for summary of 
interventions by type). Because members might have different hospitalization rates based on the 
intensity of the pre-PAM intervention, we created variables for the number of intervention days 
and for the elapsed time from first program intervention to the first PAM survey. 
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Clinical risk and utilization 
For clinical risk of hospitalization, we used a validated predictive model that incorporates age, 
gender, diagnostic information and the key lab results.27 This measure has higher predictive 
value than DxCG by making use of lab result information not easily available in systems without 
an integrated EMR.  
We used hospital days and ED visits in the previous year as covariates to control for baseline 
differences among members. We created variables for the total number of hospital days for each 
member during the six months and one year before the start of each analysis interval. We created 
variables for the total number of ED visits six months and twelve months before each member’s 
inclusion on one of the five enrolment lists, and six and twelve months before each member’s 
first PAM survey. Hospitalizations, excluding maternity and psychiatry, and ED visits include 
care at KPNC and outside facilities and were colected from the EMR and outside biling records.  
Engagement proxies 
To explore whether the predictive value of the PAM could be achieved through simpler methods, 
we created variables that could be substitutes for patient activation. We included the intake 
question “Does your physician understand your healthcare needs?” because prior research has 
shown that the PAM score was strongly associated with the Roter Doctor-patient Communication 
Scale.44 We included the support system assessment because of the possible overlap with the 
PAM construct. We also included whether a member was enroled in another care management 
program, had a primary care physician (PCP), had a visit with this PCP during the previous two 
years, and whether a member had the same PCP during the previous twelve months, because prior 
research has demonstrated the link between PCP relationship and higher quality of care.45 The 
EMR includes a web-based member portal, KP.org, which alows members to view components 
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of medical records online and to securely email with their physician. We created variables for the 
total number of logins to KP.org, and total number of sent and read messages.  
PAM Score and Level 
Raw scores for the PAM are calculated by assigning the values of 1-4 to responses from Disagree 
Strongly to Agree Strongly: patients are less likely to agree with each successive item in the 
survey (Appendix Table 14). A Rasch scoring table converts curvilinear summated raw scores to 
linear, interval scores in the range of 0 (lowest activation) to 100 (highest activation). Patients are 
classified into four activation levels (1=lowest activation, 4= highest activation) based on their 
score (Appendix Figure 5).  The four-level structure was based on theory and psychometric 
properties from the PAM’s original development.23 This structure was confirmed in subsequent 
psychometric research as different versions of a three-level structure.46,47  
Outcome measure: Hospitalization 
Our primary outcome was the number of inpatient hospitalizations and time to the first inpatient 
hospitalization during the folow-up period.  
Statistical analysis 
We analyzed the distribution of study participation rates and first PAM survey level by patient 
characteristics, testing for differences using χ2 tests and Kruskal-Walis tests. We calculated the 
annualized hospitalization rate per time at-risk by patient characteristics. We categorized the 
annualized hospitalization rate into three groups: 0, >0-1, and >1 hospitalization per year. Time 
at-risk is the duration from the first PAM survey to the study end date (or patient death). Patients 
were not at-risk during a hospitalization. To test for differences in covariates by hospitalization 
rate category, we used χ2 tests for categorical variables and Kruskal-Walis tests for continuous 
variables. 
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We used Cox proportional hazards models to examine unadjusted and adjusted relationships 
between time to first hospitalization during the folow-up period and PAM, demographics, health 
status, health condition, clinical risk, prior utilization, study characteristics, and engagement 
variables. Because participants could have completed multiple PAM surveys, and because key 
covariates changed over the course of the study, we used the counting process style of input to 
represent time-dependent repeating covariates. We created a new record in the analysis dataset 
for each folow-up PAM survey a member completed and created new values for the folowing 
covariates that could have changed: intervention days, clinical risk score, hospital days, PCP 
status, PCP visit, smoking, BMI, other care management, and chronic conditions. Each time-
dependent covariate was represented with its value in the month of the PAM survey, or its most 
recent value before that month. A patient’s observation was censored on the date of death. 
Because we did not have reliable information on disenrolment, no participants were censored for 
loss to folow-up. In exploratory data analysis, we found that very few members had gaps in 
membership during the folow-up period, and the utilization rate during gaps in enrolment was 
similar to the utilization rate during enrolment. 
We included al variables with p-values lower than 0.25 in the univariate analyses in the initial 
multivariable Cox analyses. We did not include age and gender because they are already 
included in the clinical risk score. We kept variables in the multivariable models with p-values 
<0.10, if they caused significant confounding or they improved model fit. PAM and 
race/ethnicity were retained in each model. We categorized continuous variables or combined 
categories based on linear Wald hypothesis tests. We explored PAM as a continuous variable and 
by the four PAM Levels. We explored interactions between the three key predictor variables – 
PAM, clinical risk/utilization, self-reported health status – and al other significant covariates on 
the outcome. We confirmed the proportionality assumption of the Cox model, and substituted 
variables in models displaying excessive multicolinearity. 
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For the subgroup analyses, we explored the effect of change in PAM score (in continuous and 
quartile form) for participants with multiple PAM surveys, and explored the effect of pregnancy 
for female participants. For sensitivity analyses, we explored multiple final models. We also 
constructed and tested a time to recurrent event model that used al hospitalizations in the folow-
up period. For al analyses, we did not include the approximately 1% of patients with missing 
values for self-reported health status or support system. 
Analyses were conducted using SAS version 9.2 (SAS Institute Inc., Cary, North Carolina). The 




Of the 2,973 members selected for the care management program, 1,254 did not enrol, were 
excluded by care managers, or could not be reached (Figure 2). An additional 40 members were 
initialy enroled, but were dis-enroled before December 2009 and received no additional 
interventions or atempted contacts. Of the remaining 1,679 members, 1,041 completed at least 
one PAM survey and are the subject of our analysis (“PAM cohort”). For these patients, the 
median (interquartile range) folow-up time was 570 days (458-642), and al but four folow-up 
times were greater than six months. The overal study participation rate (PAM completion/PAM 
eligible) was 62%.  
PAM eligibles were different from the PAM ineligibles (Table 1, al p≤0.01) by being more 
female (82% versus 76%); much less Hispanic (24% versus 44% Hispanic) and 42% versus 25% 
African-Americans, with slightly lower SES (16.7% versus 16.1% poverty rate, and 24.0% versus 
24.9% colege graduation rate); and more obese (56% versus 47% obese/morbidly obese). PAM 
eligibles had higher rates of asthma (29% versus 21%), hypertension (32% versus 23%), 
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diabetes/cardiovascular disease (25% versus 18%), slightly lower clinical risk (4.9 versus 5.0 
DxCG score), and higher ED visit rates (2.0/year versus 1.7/year). PAM eligibles had closer 
engagement with PCPs (89% versus 73% with recent PCP visits, and 83% versus 75% with stable 
PCP relationships). 
PAM cohort participants had a mean age of 38 years, were 84% female, and were 20% Hispanic, 
45% African-American and 26% white. The PAM cohort was different from program-enroled 
members without PAM surveys (Table 1, al p≤0.05) by being more female (84% versus 78%), 
much less Hispanic and more African-American, lower SES (17.1% versus 16.2% poverty rate; 
23.5% versus 24.8% colege graduation rate). Clinicaly, the PAM cohort was less disabled (38% 
versus 45%), more likely to be pregnant (17% versus 10%), and had lower DxCG scores (4.6 
versus 5.3), and fewer hospital days (1.2 versus 1.7). PAM participation rates were lower for the 
first three cohorts enroled in the case management program (55%, 57%, and 56%) and much 
higher for the last cohort (93%).  The PAM cohort was less likely to have a significant support 
system (25% versus 39%). Thirty-seven percent of PAM cohort participants were in the two 
lowest PAM Levels (Table 2). Lower activation patients were older (p<0.01), and had lower 
health status (p<0.01), higher disability rates (p<0.01), higher depression rates (p<0.01), higher 
hypertension rates (p=0.04), higher ED visit rates (p<0.01), and lower reported rates of their 
physicians understanding their healthcare needs (p=0.01). A total of 88% of subjects completed 
at least two PAM surveys, 63% completed at least four, and the median (interquartile range) of 
time to second PAM survey was 98 days (90-154) (Appendix Table 15). 
Hospitalizations 
The study group had a total of 532 hospitalizations during the folow-up period and 1,548 person-
years at-risk corresponding to an annual event rate of 0.34 hospitalizations. Nearly three-quarters 
had no hospitalizations and 16% had only one. Patients with higher hospitalization rates during 
the study period were older age, were more white and less Hispanic, had much lower health 
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status, had much higher rates of disability, obesity and chronic disease (except for asthma), much 
higher hospitalization risk, much higher previous utilization, more likely to have had ≤9 
intervention days, and were more likely to have read multiple secure messages (Table 3, p≤0.02 
for al).  
In univariate analysis, PAM did not have a significant relationship with hospitalization risk 
(Table 4). In multivariable analysis, the largest magnitude predictors were predicted 
hospitalization risk (fifth versus first quintile HR: 3.51, p<0.01), heart failure (HR: 1.98, p<0.01), 
and ≥3 hospital days in the previous 12 months (HR: 1.64, p=0.02).  High self-reported health 
status was associated with lower hospitalization risk (HR: 0.60, p=0.01).  
PAM was associated with hospitalization risk only in interaction with level of support system, 
although these relationships were not significant at the 5% level. Lower activation was associated 
with higher hospitalization risk among members with significant support systems (PAM Level 1, 
2, or 3 versus PAM Level 4 HR=1.57, p=0.07), and was associated with lower hospitalization risk 
among patients with some or no support system (PAM Level 1, 2, or 3 versus PAM Level 4 
HR=0.78, p=0.11). Among patients at PAM Levels 1, 2, or 3, having some/no support, compared 
to significant support, was associated, counter-intuitively, with a lower hospitalization risk (HR: 
0.59, p<0.01).  
Models with alternative covariate inclusion produced similar coefficients for PAM, clinical risk, 
and health status. A recurrent event model of time to al hospitalizations found no significant 
relationships with PAM.  In an analysis of patients with more than one PAM survey, we found 
that the change in PAM score from the most recent previous survey was not significantly related 
to hospitalization risk. 
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Discussion 
We studied whether the PAM independently predicts hospitalization in a high-risk Medicaid 
population. Controling for demographic and clinical covariates, PAM provided weak (not 
significant at 5% level) and inconsistent predictive value for hospitalization risk. The clinical 
implication is that patient activation may have limited utility in predicting hospitalizations in our 
high-risk Medicaid population, particularly when rich clinical information is available. This 
result supports the concept that hospitalization may be driven primarily by acute clinical events 
(e.g. infection, thrombosis) rather than patient behaviors (at least in the 1 to 2 year folow-up 
period of this study). 
Among the 25% of patients with a significant support system, there was some evidence (p=0.07) 
that a PAM score below the highest activation level (Level 4) was associated with increased 
hospitalization risk. Having a significant informal support system might be a proxy for higher 
healthcare needs.  
This study expands on previous literature by examining the correlation of PAM with subsequent 
hospitalization in a high-risk patient population with wel-defined clinical risk covariates. 
Previous studies have found significant relationships between PAM and hospitalization but those 
studies focused on older populations with diabetes or heart failure,37,39,40 or a general population 
served by a large health system.38 Our different results could be explained by three factors. First, 
hospitalizations for our high-risk Medicaid patients might be less preventable. A recent study in a 
safety net hospital found a large and significant relationship between PAM and readmission, a 
more preventable outcome.48 The smal number of hospitalizations in our study prevented us 
from exploring a readmission analysis. Second, our patient population had much lower activation 
scores than a nationaly representative sample: 37% were in the lowest two activation levels 
compared to 21% nationaly, and only 30% were in the highest level compared to 41% 
nationaly.49 Variation in activation might mater less in an overal lower activation population, 
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although this is also inconsistent with other PAM literature. Third, there could be systematic 
differences between KPNC’s integrated delivery system and the other environments where PAM 
has been studied. 
A central question for operational and clinical leaders is whether PAM or other patient-centered 
assessments provide a useful guide to clinical intervention. Does PAM help identify which high-
risk patients need intervention and which do not? From the Physician Group Practice 
Demonstration (PGPD)50 to ACOs, federal policy aims to give integrated delivery systems the 
opportunity and incentive to improve patient wel being at the lowest per capita cost. To improve 
the cost-effectiveness of care management interventions, patients at lower levels of activation 
might receive higher intensity interventions aimed at building a belief that what they do maters 
for their health, and patients at higher levels of activation might receive lower intensity, and less 
expensive interventions, aimed at assisting them in staying on track during times of stress. One 
large quasi-experimental study has provided some positive evidence that this tailoring approach 
works to improve outcomes and reduce utilization, but only for an employed population.21 A 
randomized study of a diabetes peer-coaching intervention found that the intervention only had 
impact among patients with low or moderate baseline self-management skils; patients with high 
self-management skils improved equaly with and without intervention.51 This intervention-
tailoring approach may be less effective in improving less preventable or behavior sensitive 
outcomes, such as this study’s 1-2 year hospitalization risk. 
The results of this study need to be interpreted within the limits of the study design. As an 
observational study, it is subject to unmeasured confounding and causality cannot be determined. 
In particular, to the extent that the care management intervention was effective, it could have 
dampened the association between PAM and hospitalization. However, with the exception of 
direct measurement of SES, rigorous measurement of social support, and health literacy, our data 
set was both rich and complete with a sophisticated clinical risk predictor, detailed measurement 
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of chronic conditions, complete historic utilization information, self-reported health status, and 
measures that could serve as proxies for patient engagement. We also used time-to-event 
statistical methods to maximize the information available from our data. However, our modest 
sample size limits our ability to detect smaler effects. Our study population is reasonably 
representative of the high-risk Medicaid group from which it was drawn, although bias is difficult 
to assess because of inconsistent effort to reach al potential participants. The apparently lower 
clinical risk in our study population compared to that of patients who did not complete at least 
one PAM survey is probably related to the underlying program design and not to biased selection. 
A disproportionately smal, and possibly lower risk, group of Hispanic patients participated in the 
study, possibly because of language barriers. 
After accounting for clinical risk, we did not find a strong association between PAM and 
hospitalization risk. The factors we found to be highly associated with hospitalization risk are not 
easily modifiable. Future randomized intervention studies are needed to test whether customizing 








2,973 potentialy eligible 
Medi-Cal enrolees invited 
into intervention 
PAM ineligible 
• 1,254 did not enrol (declined, excluded by care managers or 
could not be reached) 
• 40 dis-enroled <12/1/09 (start of PAM) and had 0 documented 
interventions or contact atempts>=12/1/09 
1,679 Enroled in 
program (“PAM 
eligible” 
638 did not complete a PAM survey 
1,041 completed at 
least one PAM survey 
(“PAM cohort”) 
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Table 1: Distribution of Member Characteristics by Participation Status  
 
Note: Column percentages for are calculated as a percent of total non-missing for that characteristic. Missing percentages are calculated as a percent of the 








Age,!mean !!36.7! !!37.7! 0.12 37.1 36.1 0.01 36.6











Missing 2 0% 2 0% 2 0%
Race
Hispanic 210 20% 190 30% 400 24% 570 44% 970 33%
African!American 470 45% 231 36% 701 42% 319 25% 1020 34%
Other 90 9% 60 9% 150 9% 141 11% 291 10%
White!nonLHispanic 271 26% 156 24% 427 25% 264 20% 691 23%
0.00 0.00
Missing 1 0% 1 0% 1 0%
Preferred!Verbal!Language!(as!of!12/09)
English 1005 97% 596 96% 1601 96% 1107 94% 2708 96%
Spanish!and!other 35 3% 26 4% 61 4% 65 6% 126 4%
Total!nonLmissing 1040 100% 622 100% 1662 100% 1172 100% 2834 100%
0.39 0.02
Missing 1 0% 16 3% 0.00 17 1% 122 9% 0.00 139 5%
Home!Medical!Center
East!Bay 247 24% 153 24% 400 24% 334 26% 734 25%
Napa/Solano 262 25% 215 34% 477 28% 260 20% 737 25%
North!Valey 288 28% 134 21% 422 25% 342 26% 764 26%
South!Sacramento 244 23% 136 21% 380 23% 357 28% 737 25%
0.00 0.00
Missing 1 0% 1 0%
Poverty!Rate!(in!home!zip),!mean 17.1% 16.2% 0.01 16.7% 16.1% 0.01 16.5%
Colege!Grad.!Rate!(in!home!zip),!mean 23.5% 24.8% 0.02 24.0% 24.9% 0.01 24.4%
Ful!or!partLtime!work!(at!enrolment) 227 22% 109 20% 0.36 336 21% 28 29% 0.13 364 22%
Total!nonLmissing 1034 100% 552 100% 1586 100% 98 100% 1684 100%
Missing 7 1% 86 13% 0.00 93 6% 1196 92% 0.00 1289 43%
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Table 1 (continued): Distribution of Member Characteristics by Participation Status 
 
Note: Column percentages for are calculated as a percent of total non-missing for that characteristic. Missing percentages are calculated as a percent of the 



















Poor 123 12% 95 17% 218 14% 29 13% 247 14%
Fair 308 30% 166 29% 474 30% 50 23% 524 29%
Good 400 39% 185 33% 585 37% 80 37% 665 37%
Very!Good 135 13% 80 14% 215 13% 39 18% 254 14%
Excelent 64 6% 39 7% 103 6% 17 8% 120 7%
Total!with!response 1030 100% 565 100% 1595 100% 215 100% 1,810 100%
0.03 0.18
Missing!survey/no!response!to!question 11 1% 73 13% 0.00 84 5% 1079 83% 0.00 1163 39%
Smoking!Status!(at!enrolment)
Never!Smoked 483 47% 281 46% 764 47% 541 49% 1305 48%
Not!Current!Smoker 255 25% 129 21% 384 24% 257 23% 641 23%
Current!Smoker 282 28% 197 32% 479 29% 314 28% 793 29%
Total!with!Information 1020 100% 607 100% 1627 100% 1112 100% 2739 100%
0.07 0.67
Unknown!(no!information!in!EMR) 21 2% 31 5% 0.00 52 3% 182 14% 0.00 234 8%
BMI!category!(%!of!nonmissing)
Normal/Underweight 197 19% 142 23% 339 21% 283 25% 622 22%
Overweight 242 23% 136 22% 378 23% 316 28% 694 25%
Obese 364 35% 225 37% 589 36% 364 32% 953 34%
Morbidly!Obese 227 22% 111 18% 338 21% 172 15% 510 18%
Total!with!information 1030 100% 614 100% 1644 100% 1135 100% 2779 100%
0.09 0.00
Unknown!(no!information!in!EMR) 11 1% 24 4% 0.00 35 2% 159 12% 0.00 194 7%
Substance!Abuse,!self\report!(at!enrolment) 127 12% 101 18% 0.00 228 14% 17 17% 0.45 245 15%
Total!non\missing 1034 100% 552 100% 1586 100% 98 100% 1684 100%
Missing 7 1% 86 13% 0.00 93 6% 1196 92% 0.00 1289 43%
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Table 1 (continued): Distribution of Member Characteristics by Participation Status 
 
Note: Column percentages for are calculated as a percent of total non-missing for that characteristic. Missing percentages are calculated as a percent of the 



















Missing 1 0% 1 0%
Pregnancy!(%!of!females) 151 17% 51 10% 0.00 202 15% 120 12% 0.09 322 14%
Depression!registry!(as!of!12/09) 397 38% 252 39% 0.66 649 39% 431 33% 0.02 1080 36%
Asthma!registry!(as!of!12/09) 308 30% 172 27% 0.33 480 29% 274 21% 0.00 754 25%
Hypertention!registry!(as!of!12/09) 325 31% 207 32% 0.67 532 32% 299 23% 0.00 831 28%
Heart!Failure!registry!(as!of!12/09) 36 3% 30 5% 0.21 66 4% 50 4% 0.93 116 4%
Diabetes/cardiovascular!registry!(as!of!12/09) 254 24% 166 26% 0.52 420 25% 239 18% 0.00 659 22%
Clinical&Risk
DxCG!Score!(mean) 4.6 5.3 0.00 4.9 5.0 0.00 4.9
ED!Visits!(12!mos!prior!to!list),!mean 2.0 2.1 0.26 2.0 1.7 0.00 1.9
Hospital!Days!(12!mos!prior!to!list),!mean 1.2 1.7 0.00 1.4 1.6 0.78 1.5
Study&Characteristics
List!Release!Date
FebW08 217 21% 181 28% 398 24% 304 23% 702 24%
AugW08 228 22% 175 27% 403 24% 263 20% 666 22%
DecW08 204 20% 161 25% 365 22% 272 21% 637 21%
JunW09 173 17% 104 16% 277 16% 251 19% 528 18%
DecW09 219 21% 17 3% 236 14% 204 16% 440 15%
Died!before!12/1/09 0 0% 0 0% 0 0% 43 3% 43 1%
0.00 0.05
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Table 1 (continued): Distribution of Member Characteristics by Participation Status 
 
Note: Column percentages for are calculated as a percent of total non-missing for that characteristic. Missing percentages are calculated as a percent of the 









Significant 256 25% 218 39% 474 30% 43 44% 517 31%
Some 716 69% 299 54% 1015 64% 54 55% 1069 63%
None 62 6% 35 6% 97 6% 1 1% 98 6%












Missing 7 1% 86 13% 0.00 93 6% 1196 92% 0.00 1289 43%
>=1!PCP!visit!prior!2!yrs!(as!of!12/09) 926 89% 576 90% 0.78 1502 89% 946 73% 0.00 2448 82%
PCP!status!in!last!12!months!(as!of!12/09)
Same!PCP,!no!change 871 84% 522 82% 1393 83% 965 75% 2358 79%
PCP!added 36 3% 14 2% 50 3% 43 3% 93 3%
PCP!changed 132 13% 86 13% 218 13% 160 12% 378 13%
No!PCP!as!of!12/09 2 0% 16 3% 18 1% 126 10% 144 5%
Enroled!in!care!management!(as!of!12/09) 43 4% 36 6% 0.17 79 5% 39 3% 0.02 118 4%
>=1!login!to!kp.org!prior!12!mos 224 22% 145 23% 0.61 369 22% 281 22% 0.88 650 22%
Sent!secure!messages!prior!12!mos,!mean 1.3 1.2 0.98 1.3 1.1 0.98 1.2
MD!understanding!of!needs!(at!enrolment)
0.00 0.00
Poor 41 4% 26 5% 67 4% 9 4% 76 4%
Fair 99 10% 63 12% 162 11% 23 11% 185 11%
Good 281 28% 137 26% 418 27% 64 30% 482 28%
Very!Good 264 27% 123 23% 387 25% 44 21% 431 25%
Excelent 310 31% 181 34% 491 32% 71 34% 562 32%
Total!with!response 995 100% 530 100% 1525 100% 211 100% 1736 100%
0.30 0.69
Missing!survey/no!response!to!question 46 4% 108 17% 0.00 154 9% 1083 84% 0.00 1237 42%
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Table 2: PAM Level by Member Characteristics 
 




Age,%mean 40.2 39.7 38.0 36.5 0.00 38.2
Gender,%male 32 18% 38 18% 43 14% 51 15% 0.60 164 16%
Race
Hispanic 29 16% 45 21% 54 18% 82 24% 210 20%
African@American 79 44% 89 42% 141 47% 161 46% 470 45%
Other 14 8% 21 10% 30 10% 25 7% 90 9%
White%non@Hispanic 57 32% 57 27% 78 26% 79 23% 271 26%
Language,%Spanish 3 2% 9 4% 10 3% 14 4% 0.50 36 3%
Home%Medical%Center
East%Bay 24 13% 43 20% 70 23% 110 32% 247 24%
Napa/Solano 36 20% 56 26% 82 27% 88 25% 262 25%
North%Valey 80 45% 62 29% 72 24% 74 21% 288 28%
South%Sacramento 39 22% 51 24% 79 26% 75 22% 244 23%
Health"Status"and"Conditions
Health%Status:%Very%good/excelent%(11%missing)%(at%enrolment) 16 9% 26 12% 59 19% 98 28% 0.00 199 19%
Current%smoker 57 32% 63 30% 86 28% 83 24% 0.35 289 28%
Morbidly%obese 46 26% 56 26% 62 20% 70 20% 0.30 234 22%
Disabled%(at%enrolment) 95 53% 96 45% 106 35% 102 29% 0.00 399 38%
Pregnancy%(%of%females) 19 13% 32 18% 42 16% 58 20% 0.41 151 17%
Depression%registry 99 55% 93 44% 102 34% 105 30% 0.00 399 38%
Hypertention%registry 76 42% 77 36% 88 29% 101 29% 0.03 342 33%
Heart%Failure%registry 6 3% 13 6% 10% 8 2% 0.13 37 4%

















Table 2 (continued): PAM Level by Member Characteristics 
 





Hospitalization+risk,+mean 7.8% 7.8% 6.0% 5.1% 0.00 6.4%
>=3+ED+Visits+(12+mo+before+first+PAM) 60 34% 68 32% 78 26% 69 20% 0.00 275 26%
>=3+Hospital+days+(12+mo+before+first+PAM) 14 8% 20 9% 26 9% 21 6% 0.51 81 8%
Study"Characteristics
>=9+Interventions+(six+mo+before+first+Pam) 17 9% 13 6% 20 7% 25 7% 0.04 75 7%
List+date
FebP08 49 27% 53 25% 58 19% 57 16% 217 21%
AugP08 40 22% 43 20% 64 21% 81 23% 228 22%
DecP08 27 15% 38 18% 69 23% 70 20% 204 20%
JunP09 32 18% 33 16% 49 16% 59 17% 173 17%
DecP09 31 17% 45 21% 63 21% 80 23% 219 21%
Significant+Support+System,+(7+missing)+(at+enrolment) 27 15% 45 21% 86 28% 98 28% 0.01 256 25%
Enroled+in+care+management 10 6% 18 8% 23 8% 20 6% 0.55 71 7%
PCP+visit+in+the+last+two+years 172 96% 195 92% 275 91% 311 90% 0.90 953 92%
PCP+changed+or+added+in+last+12+months 21 12% 31 15% 39 13% 61 18% 0.29 152 15%
PCP+added 1 1% 1 0% 2 1% 7 2% 0.20 +++++11+ 1%
PCP+changed+in+last+12+months 20 11% 30 14% 37 12% 54 16% 0.52 +++++141+14%
PCP+no+change+in+last+12+months 21 12% 31 15% 38 13% 55 16% 0.57 +++++145+14%
>=2+Read+secure+messages+in+past+12+months 33 18% 39 18% 51 17% 69 20% 0.85 +++++192+18%
















Table 3: Annualized Hospitalization Rate by Member Characteristics 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables.  
P"value
Socio,Demographic
Age$(mean) 36.5$ 39.9$ 46.8$ 0.00 38.2$$$
Gender,$male 12116% 15$$$ 10% 28$$$ 22% 0.04 164 16%
Race
Hispanic 17122% 2618% 1310% 210 20%
AfricanBAmerican 34945% 6947% 5242% 470 45%
Other 60 8% 13 9% 1714% 90 9%
White$nonBHispanic 18824% 4027% 4334% 271 26%
Home$Medical$Center
East$Bay 18524% 3926% 2318% 247 24%
Napa/Solano 18524% 4329% 3427% 262 25%
North$Valey 21428% 3826% 3629% 288 28%
South$Sacramento 18424% 2819% 3226% 244 23%
Health"Status"and"Conditions
Health$Status:$Very$good/excelent$(at$enrolment) 17022% 2215% 7 6% 0.00 199 19%
Current$smoker 21027% 3524% 4435% 0.18 289 28%
Morbidly$obese 15320% 4631% 3528% 0.01 234 22%
Disabled$(at$enrolment) 26134% 6544% 7358% 0.00 399 38%
Depression$registry 26635% 6645% 6754% 0.00 399 38%
Asthma$registry 22730% 4530% 4939% 0.20 321 31%
Hypertention$registry 20627% 6544% 7157% 0.00 342 33%
Heart$Failure$registry 14 2% 7 5% 1613% 0.00 37 4%















 Table 3 (continued): Annualized Hospitalization Rate by Member Characteristics 
 




Hospitalization+risk,+mean 4.9% 7.0% 14.6% 0.00 6.4%
>=3+ED+Visits,+prior+12+months 16622% 5436% 5544% 0.00 275 26%
>=3+Hospital+days,+prior+12+months 36 5% 10 7% 3528% 0.00 81 8%
Study"Characteristics
>=9+Intervention+days,+prior+6+months 46 6% 13 9% 1613% 0.02 75 7%
Engagement/activation"proxies
PAM+Level
1st 11815% 3524% 2621% 179 17%
2nd 15220% 3322% 2722% 212 20%
3rd 23130% 3826% 3427% 303 29%
4th 26735% 4228% 3830% 347 33%
Support+System,+Significant+(at+enrolment) 17823% 4027% 3830% 0.26 256 25%
Enroled+in+care+management 46 6% 12 8% 1310% 0.18 71 7%
Had+PCP+Visit+in+the+last+two+years 69590% 13692% 12298% 0.74 953 92%
PCP+changed+or+added+in+last+12+mos. 11615% 2215% 1411% 0.57 152 15%
>=2+Read+secure+messages,+prior+12+months 12416% 3524% 3326% 0.01 192 18%














Table 4: Unadjusted and Adjusted Cox Proportional Hazard Estimates:  
Time to First Hospitalization 
 
Note: al comparisons use 90% two-sided Wald confidence intervals 
1 significantly higher than 2nd and 3rd quintiles 
2 significantly higher than 2nd, 3rd, and 4th quintiles 
3 significantly higher than Some/none at same PAM Level (p<0.01), and significantly higher than 




















































































3.81 (2.7915.19) 1.64 (1.1612.33)
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>=2 1.62 (1.2812.03) 1.52 (1.1911.94)
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Manuscript	  II:	  Predicting	  emergency	  department	  visits	  using	  the	  Patient	  
Activation	  Measure	  
Importance: Integrated delivery systems increasingly seek to reduce Emergency Department 
(ED) overuse. However, most models used to predict ED visits incorporate unmodifiable patient 
factors such as prior utilization, health status, clinical severity, and demographic data. Models 
that include potentialy modifiable measures may be more useful for identifying subsets of high-
risk patients for tailored interventions. 
Objective: To estimate the predictive value of the Patient Activation Measure (PAM) on ED 
visits among high-risk Medicaid patients.  
Design: Retrospective cohort study from December 2009 through December 2011. 
Setting: Four medical centers within Kaiser Permanente Northern California (KPNC), a large 
integrated healthcare delivery organization.  
Participants: We studied high-risk Medicaid patients aged 18-62 who had at least 10 months of 
KPNC membership, lived at home, and were enroled in a care management program to reduce 
future utilization. High risk was defined as 2-8 ED visits or hospitalizations in the prior year or 
Diagnosis Cost Group (DxCG) score of >= 3. From this eligible population, 1,041 of 1,676 (62%) 
patients completed a PAM survey and are the subject of this analysis. 
Main Outcome Measure: Number and time to emergency department visits. 
Results: Participants were typical of non-elderly, high-cost California Medicaid patients: mean 
age, 38 years; 20% Hispanic; 45% African-American; DxCG mean score, 4.6; 55% obese or 
morbidly obese; 38% disabled. There were 3,241 ED visits during folow-up and 1,550 person-
years at risk (event rate=2.1 ED visits/person-year). Controling for covariates with a Cox 
proportional hazards model of time to recurrent events, Level 1 PAM scores were associated with 
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higher ED visit risk among patients with unstable PCP relationships (HR: 1.40, p<0.01), with the 
effect concentrated among African-American (HR: 1.45, p<0.01) and Hispanic patients (HR: 
1.47, p=0.05). ED visit risk was also strongly associated with clinical factors and prior 
utilization. 
Conclusions and Relevance: In a high-risk Medicaid population, lower PAM scores were 
associated with higher ED visit risk among specific patient subgroups. Randomized intervention 
studies are needed to test whether tailoring interventions to increase patient activation levels in 
these subgroups can reduce preventable ED use.  
Introduction 
The concentration of expenditures is a fundamental characteristic of healthcare markets. Based 
on the Medical Expenditure Panel Survey (MEPS), 1% of the United States population accounted 
for 22% of healthcare costs in 2010, and 5% accounted for 50% of costs.1 About one-third of this 
top 5% population in 2010 were also in the top 5% group in 2009.1 Successful efforts to control 
healthcare costs must effectively address care for this population. 
A substantial portion of costs in these highest risk patient populations may be preventable.3 
Research has found that 8.4% of adult emergency department (ED) visits were preventable,33 and, 
within a high-cost Medicare population, that 43% of ED visits were preventable.2 Prior studies 
have found that clinical risk,26-30 self-reported health status,31,32 and demographic factors (race, 
socioeconomic status, insurance status)1,25,33-35 are correlated with high or preventable utilization. 
Identifying these unmodifiable risk factors does not, however, help to inform the design of 
interventions to reduce healthcare utilization. Indeed, a comprehensive evaluation of Medicare's 
six major disease management and care coordination demonstration programs found litle or no 
effect on hospital admissions or net Medicare expenditures.10 
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Measuring patient activation offers one potentialy innovative approach to guiding interventions 
to reduce future utilization.22 Patient activation is defined as a patient’s knowledge, skils, beliefs, 
and confidence for engaging in self-management behavior, and has been standardized through the 
13-item Patient Activation Measure (PAM) (Appendix Table 14).36 While there is modest 
evidence that the PAM independently predicts future utilization after controling for clinical risk, 
health status, and demographic factors,37-40 this relationship has not been studied within the high-
risk, non-elderly Medicaid population that represents one of the major sources of our nation’s 
health expenditures. We tested the hypothesis that PAM scores predict ED visits in this high-risk 




We conducted a retrospective cohort analysis of high-risk Medicaid patients enroled in a care 
management program implemented within an integrated health system. The program included 
assessment of patient activation using PAM surveys. Members were eligible if they were current 
Kaiser Permanente Northern California (KPNC) Medicaid members and: 
1. Had at least 10 months of Medicaid membership, and were not a Medicare member; 
2. Were ages 18 through 62; 
3. Had two to eight ED visits or hospitalizations (excluding maternity) in the past twelve 
months or Diagnosis Cost Group (DxCG)41 prospective score of greater than 3 (4 for the 
first two enrolment groups); and,  
4. Were not a resident of a skiled nursing facility or hospice. 
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Seting and Participants 
KPNC is a nonprofit, integrated healthcare delivery system providing comprehensive medical 
care to a diverse population of approximately 3.4 milion members. Distribution of patient 
demographic and socioeconomic factors is similar to that of the area population, except at the 
extremes of the income distribution.42 Al healthcare utilization is recorded within a 
comprehensive electronic medical record (EMR).  
Our study period begins at the point of completion of the first PAM survey, as early as December 
2009, and ends at the time of the patient's death or December 31, 2011, the end of the care 
management program. We did not track utilization beyond December 2011 because the intensity 
of interventions was a key covariate that ended at that time. 
Our study period is the second phase of the care management program that began 22 months 
earlier. Care managers at four geographicaly defined service areas received lists of eligible 
Medicaid members in February 2008, August 2008, December 2008, June 2009, and December 
2009. Care managers enroled members in the program and completed a baseline patient 
assessment. Each service area had a dedicated team comprising one registered nurse, two 
licensed vocational nurses, and one licensed clinical social worker. Beginning in December 
2009, al care managers were trained in motivational interviewing and PAM administration. We 
considered members to be "PAM eligible" if they met the folowing criteria: 
1. Coded as "enroled" as of or at any time after December 1, 2009; or, 
2. Had >=1 intervention or atempted contact after December 1, 2009. 
Care managers were instructed to atempt a PAM survey and conduct interventions at least every 
three months; however, this practice varied. As part of a quality improvement project, care 
managers administered the PAM by phone, occasionaly in person, and by mail before any care 
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management intervention. Many care managers folowed up with members after a hospitalization 
or ED visit. Members received a $10 gift card for completing their first PAM survey.  
Sources of Analytic Variables 
We obtained age, gender, date of death, membership status, and home zip code from KPNC 
membership files; and obtained race/ethnicity, spoken language, smoking status, disability, and 
body mass index (BMI) from the EMR. Chronic conditions (e.g. hypertension, diabetes, asthma, 
heart failure, and depression) were identified using KPNC’s population care registry archives, 
which are updated quarterly. For socioeconomic status (SES), we obtained zip code-level poverty 
rate, median household income, high school graduation rate, and colege graduation rate from the 
United States Census Bureau’s 2007-2011 American Community Survey (ACS). We created a 
binary pregnancy variable if a member had any maternity hospital encounters from September 
2009 through June 2012. 
When atempting to enrol members, care managers asked about working status, informal (non-
health care provider) support system (“none”, “some”, or “significant”), and substance use; or, 
care managers assessed these three variables from a chart review. Care managers also 
administered a six-item intake questionnaire (Appendix Table 16) on experience of care and 
health status (with wording very similar to the first question on the SF-36 survey, with identical 
response categories).43  
We created variables for the number of unique case management intervention days six months 
and twelve months before each analysis interval (see Appendix Table 20 for summary of 
interventions by type). Because members might have different ED visit rates based on the 
intensity of the pre-PAM intervention, we created variables for the number of intervention days 
and for the elapsed time from first program intervention to the first PAM survey. 
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Clinical risk and utilization 
For clinical risk of hospitalization, we used a validated predictive model that incorporates age, 
gender, diagnostic information and the key lab results.27 This measure has higher predictive 
value than the DxCG by making use of lab result information not easily available in systems 
without an integrated EMR.  
We used hospital days and ED visits in the previous year as covariates to control for baseline 
differences among members. We created variables for the total number of hospital days for each 
member during the six months and one year before the start of each analysis interval. We created 
variables for the total number of ED visits six months and twelve months before each member’s 
inclusion on one of the five enrolment lists, and six and twelve months before each member’s 
first PAM survey. Hospitalizations, excluding maternity and psychiatry, and ED visits include 
care at KPNC and outside facilities and were colected from the EMR and outside biling records.  
Engagement proxies 
To explore whether the predictive value of the PAM could be achieved through simpler methods, 
we created variables that could be substitutes for patient activation. We included the intake 
question “Does your physician understand your healthcare needs?” because prior research has 
shown that PAM score was strongly associated with the Roter Doctor-patient Communication 
Scale.44 We included the support system assessment because of the possible overlap with the 
PAM construct. We also included whether a member was enroled in another care management 
program, had a primary care physician (PCP), had a visit with this PCP during the previous two 
years, and whether a member had the same PCP during the previous twelve months, because prior 
research has demonstrated the link between PCP relationship and higher quality of care.45 The 
EMR includes a web-based member portal, KP.org, which alows members to view components 
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of medical records online and to securely email with their physician. We created variables for the 
total number of logins to KP.org, and total number of sent and read messages.  
PAM Score and Level 
Raw scores for the PAM are calculated by assigning the values of 1-4 to responses from Disagree 
Strongly to Agree Strongly: patients are less likely to agree with each successive item in the 
survey (Appendix Table 14). A Rasch scoring table converts curvilinear summated raw scores to 
linear, interval scores in the range of 0 (lowest activation) to 100 (highest activation). Patients are 
classified into four activation levels (1=lowest activation, 4= highest activation) based on their 
score (Appendix Figure 5).  The four-level structure was based on theory and psychometric 
properties from the PAM’s original development.23 This structure was confirmed in subsequent 
psychometric research as different versions of a three-level structure.46,47  
Outcome measure: ED visits 
Our primary outcome was the number of ED visits and time to ED visits during the folow-up 
period.  
Statistical analysis 
We calculated the annualized ED visit rate per time at-risk by patient characteristics. We 
categorized the annualized ED visit rate into five groups: 0, >0-1, >1-2, >2-3, and >3 ED visits 
per year. Time at-risk is the duration from the first PAM survey to the study end date (or patient 
death). Patients were not at-risk for ED visits during a hospitalization. To test for differences in 
covariates by ED visit rate category, we used χ2 tests for categorical variables and Kruskal-Walis 
tests for continuous variables. We present the first PAM survey Level by patient characteristic, 
testing for differences using χ2 tests and Kruskal-Walis tests. 
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We used a conditional recurrent event gap time (GT) model to examine unadjusted and adjusted 
relationships between time to al ED visits during the folow-up period and PAM, demographic, 
health status, health condition, clinical risk, prior utilization, study characteristics (e.g. date list 
released to care managers, time from enrolment to first PAM), and engagement variables. In the 
GT model, a member was only at risk for a subsequent event after a prior event had occurred.52 
Folow-up time was measured as the days since the previous ED visit, and was reset to zero after 
each ED visit. A stratum variable indicated the specific ED visit for which a member was at risk. 
Because participants completed multiple PAM surveys, and because key covariates changed over 
time, we used the counting process style of input to represent time-dependent repeating 
covariates. We created a new dataset record for each folow up PAM survey, for each ED visit, 
and for each hospitalization, and created new values for the folowing covariates that could have 
changed: intervention days, clinical risk score, hospital days, PCP, PCP visit, PCP change status, 
smoking, BMI, other care management, and chronic conditions. Each time-dependent covariate 
was represented with its value in the month of the start time for each at-risk period, or its most 
recent value before that month. A patient’s observation was censored on the date of death. 
Because we did not have reliable information on disenrolment, no participants were censored for 
loss to folow-up.  
We included al variables with p-values lower than 0.25 in the univariate analyses in the initial 
multivariable analyses. We did not include age and gender because they were already included in 
the clinical risk score. We kept variables in the multivariable models with p-values <0.10, if they 
caused significant confounding or they improved model fit. We retained race/ethnicity in the 
models to permit exploration of PAM interactions. We categorized continuous variables, or 
combined categories, based on linear Wald hypothesis tests. We explored PAM as a continuous 
variable, and according to the predefined four PAM Levels. We explored interactions between 
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the three key predictor variables – PAM, clinical risk, self-reported health status – and al other 
significant covariates on the outcome.  
Because the hazards for ED visits appeared non-proportional over time, interactions of some 
covariates with the log of analysis time were included in the models to adjust for this time 
dependence. Because they were highly influential on the statistical significance of some of the 
estimated regression coefficients, the three extreme outliers with very high ED visit rates were 
excluded from the regression analysis. We also checked for multicolinearity and made 
appropriate adjustments. 
For the subgroup analyses, we explored the effect of a change in PAM score (in continuous and 
quartile form) for participants with multiple PAM surveys, and explored the effect of pregnancy 
for female participants. For sensitivity analyses, we tested a variety of final models with different 
combinations of covariates and specification of variables. For the approximately 1% of patients 
with missing values on some intake questions, we created a response level for “unknown,” and 
used linear Wald tests to decide whether to combine “unknown” with other categories. 
Analyses were conducted using SAS version 9.2 (SAS Institute Inc., Cary, North Carolina). The 
KPNC and Johns Hopkins Bloomberg School of Public Health IRBs approved this study. 
Results 
Study Participants 
Of the 2,973 members selected for the care management program, 1,254 did not enrol, were 
excluded by care managers or could not be reached (Figure 2). An additional 40 members were 
initialy enroled, but were dis-enroled before December 2009 and received no additional 
interventions or atempted contacts. Of the 1679 members who were enroled in the program, 
1,041 completed at least one PAM survey and are the subject of our analysis (“PAM cohort”). In 
these patients, the median (interquartile range) folow-up time was 570 days (458-642), and al 
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but four folow-up times were greater than six months. The overal study participation rate (PAM 
completion/PAM eligible) was 62%.  
PAM eligibles were different from the PAM ineligibles (Table 1, al p≤0.01) by being more 
female, much less Hispanic and much more African-American, with slightly lower SES (higher 
poverty rate and lower colege graduation rate), and more obese. PAM eligibles had higher rates 
of asthma, hypertension, diabetes/cardiovascular disease, slightly lower DxCG scores, and higher 
prior ED visit rates, and closer engagement with PCPs. 
PAM cohort patients had a mean age of 38 years, were 84% female, and were 20% Hispanic, 
45% African-American and 26% white. Program enrolees who completed at least one PAM 
differed in several ways from program enrolees without surveys (Table 1, al p≤0.05): they were 
more likely to be female (84% versus 78%), much less Hispanic and more African-American, 
with lower SES (17.1% versus 16.2% poverty rate; 23.5% versus 24.8% colege graduation rate). 
Clinicaly, the PAM cohort was less disabled (38% versus 45%), more likely to be pregnant (17% 
versus 10%), and had lower DxCG scores (4.6 versus 5.3), and fewer previous hospital days (1.2 
versus 1.7). PAM participation rates were lower for the first three cohorts enroled in the case 
management program (55%, 57%, and 56%) and much higher for the last cohort (93%).  The 
PAM cohort was less likely to have a significant support system (25% versus 39%). 
Thirty-seven percent of PAM cohort participants were in the lowest two PAM Levels (Table 5). 
Lower activation patients were older (p<0.01), and had lower health status (p<0.01), higher 
disability rates (p<0.01), higher depression rates (p<0.01), higher hypertension rates (p=0.04), 
higher ED visit rates (p<0.01), and lower reported rates of their physicians understanding their 
healthcare needs (p=0.01). A total of 88% of subjects completed at least two PAM surveys, 63% 
completed at least four, and the median (interquartile range) of time to second PAM survey was 
98 days (90-154) (Appendix Table 15). 
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ED Visits 
The study cohort had a total of 3,241 ED visits during the folow-up period and 1,550 person-
years at-risk for an event rate of 2.1 ED visits/person-year. Excluding the three extreme outliers 
(0.2% of the study population) with very high ED visit rates (75, 124, and 234 visits during the 
folow-up period), the study group had a total of 2,808 ED visits for an event rate of 1.8/person-
year. Thirty percent had no ED visits and 20% had only one (Appendix Table 18). Patients with 
higher ED visit rates were different by race (with an inconsistent patern), and had higher rates of 
depression and asthma, much higher hospitalization risk, much higher previous ED utilization, 
and lower PAM scores (Table 6, al p≤0.05).  
In univariate analysis, being in the lowest activation level (PAM Level 1) was associated with a 
smal increase in ED visit risk (HR: 1.13 [90% CL 1.03-1.24]) (Table 7).  
In multivariable regression the effects with the largest magnitude on future ED visit risk were 
hospitalization risk (HR for 4th quintile: 1.59 [90% CL 1.39-1.82], HR for 5th quintile: 1.71 [90% 
CL 1.45-2.01]) and baseline ED visits (3-7 ED visit HR: 1.97 [90% CL 1.75-2.22], 8+ ED visit 
HR: 3.24 [90% CL 2.70-3.88]). PAM was significantly correlated with ED visit risk only among 
patients who changed PCPs (Table 8). This correlation was limited to patients at PAM Level 1. 
Being in PAM Level 1 and not having a stable PCP relationship was associated with 40% higher 
ED risk (p<0.01), particularly among African-American (HR: 1.45, p<0.01) and Hispanic patients 
(HR: 1.47, p=0.05) (although the sample sizes in these two-way interaction subgroups were 
smal).  Being in PAM Level 1 and of “other” race (mostly Asian) was associated with lower ED 
visit risk, however this effect was strongly influenced by a very smal number of extreme 
observations. 
Alternative model specifications produced similar coefficients for PAM, clinical risk, and health 
status. In the analysis of the subgroup of patients with more than one PAM survey (n=915), we 
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found that change in PAM score from the most recent previous survey was not related to ED visit 
risk.  
Discussion 
We studied whether the PAM independently predicted ED visits in a high-risk Medicaid 
population. We found an independent association between PAM Level 1 (lowest activation) and 
ED visit risk among the 15% of participants without stable PCP relationships. These results 
suggest that PAM could be used to identify patients with higher and modifiable ED visit risk 
within a broader population of high-risk patients. Moreover, potential interventions to reduce ED 
visit risk could include efforts to increase PAM and changes to ensure a more stable PCP 
relationship. 
This study expands on previous literature by examining PAM and utilization within a litle 
studied and high-cost patient population. We also had rich clinical data and detailed information 
on utilization and its timing. Previous studies have found significant relationships across al 
subgroups of patients between PAM and ED visits, but those studies focused on older populations 
with diabetes or heart failure,37,39 or a very large sample of a high-PAM-score population served 
by a large health system.38 Our results are similar to the PAM diabetes study that found increased 
odds of one ED visit between PAM Level 1 and 4 (OR = 1.8, 95% CL 1.4-2.2), but no significant 
differences among Levels 2, 3 and 4.39 Our patient population had much lower activation scores 
than a nationaly representative sample: 37% were in the lowest two activation levels compared to 
21% nationaly, and only 30% were in the highest level compared to 41% nationaly.49 Our 
results could also be different because of systematic differences between KPNC’s integrated 
delivery system and the other environments where PAM has been studied. 
A central question for operational and clinical leaders is whether PAM or other patient-centered 
assessments provide a useful guide to clinical intervention. Does PAM help identify which high-
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risk patients need intervention and which do not? From the Physician Group Practice 
Demonstration (PGPD)50 to Accountable Care Organizations (ACOs), federal policy aims to give 
integrated delivery systems the opportunity and incentive to improve patient wel being at the 
lowest per capita cost. To improve the cost-effectiveness of care management, patients at lower 
levels of activation might receive higher intensity interventions aimed at building a belief that 
what they do maters for their health, and patients at higher levels of activation might receive 
lower intensity, and less expensive interventions, aimed at assisting them in staying on track 
during times of stress. One large quasi-experimental study has provided some positive evidence 
that this tailoring approach works to improve outcomes and reduce utilization, but only for an 
employed population.21 A randomized study of a diabetes peer-coaching intervention found that 
the intervention only had impact among patients with low or moderate baseline self-management 
skils; patients with high self-management skils improved equaly with and without 
intervention.51 This intervention-tailoring approach is probably more effective in improving 
behavior sensitive outcomes, such as this study’s ED visit rate. 
The results of this study need to be interpreted within the limits of the study design. As an 
observational study, it is subject to unmeasured confounding and causality cannot be determined. 
In particular, to the extent that the care management intervention was effective, it could have 
dampened the association between PAM and ED visits. However, with the exception of direct 
measurement of SES, rigorous measurement of social support, and health literacy, our data set 
was both rich and complete with a sophisticated clinical risk predictor, detailed measurement of 
chronic conditions, complete historic utilization information, self-reported health status, and 
measures that could serve as proxies for patient engagement. In our model, it is likely that race is 
functioning as a proxy for unmeasured variables. We also use statistical methods to maximize the 
information from our data: time-to-event conditional recurrent event models. However, our 
modest sample size limits our ability to detect smaler effects. Our study population is reasonably 
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representative of the high-risk Medicaid group from which it was drawn, although bias is difficult 
to assess because of inconsistent effort to reach al potential participants. The apparently lower 
clinical risk in our study population compared to patients who did not complete at least one PAM 
survey is probably related to the underlying program design and not to biased selection. A 
disproportionately smal, and possibly lower risk, group of Hispanic patients participated in the 
study, possibly because of language barriers. 
We found associations between decreased PAM and increased ED visit risk among subgroups of 
patients. The other factors we found to be highly associated with ED visit risk are not easily 
modifiable. Future randomized intervention studies are needed to test whether customizing 




Table 5: PAM Level by Patient Characteristics 
 




Mean%Age 40.2 39.7 38.0 36.5 0.00 38.2
Gender,%male 32 18% 38 18% 43 14% 51 15% 0.60 164 16%
Race
Hispanic 29 16% 45 21% 54 18% 82 24% 210 20%
AfricanAAmerican 79 44% 89 42% 141 47% 161 46% 470 45%
Other 14 8% 21 10% 30 10% 25 7% 90 9%
White%nonAHispanic 57 32% 57 27% 78 26% 79 23% 271 26%
Language,%Spanish 3 2% 9 4% 10 3% 14 4% 0.50 36 3%
Home%Medical%Center
East%Bay 24 13% 43 20% 70 23% 110 32% 247 24%
Napa/Solano 36 20% 56 26% 82 27% 88 25% 262 25%
North%Valey 80 45% 62 29% 72 24% 74 21% 288 28%

















Health%Status:%Very%good/excelent%(11%missing)%(at%enrolment) 16 9% 26 12% 59 19% 98 28% 0.00 199 19%
Current%smoker 57 32% 63 30% 86 28% 83 24% 0.35 289 28%
Morbidly%obese 46 26% 56 26% 62 20% 70 20% 0.30 234 22%
Disabled%(at%enrolment) 95 53% 96 45% 106 35% 102 29% 0.00 399 38%
Pregnancy%(%of%females) 19 13% 32 18% 42 16% 58 20% 0.41 151 17%
Depression%registry 99 55% 93 44% 102 34% 105 30% 0.00 399 38%
Hypertention%registry 76 42% 77 36% 88 29% 101 29% 0.03 342 33%
Heart%Failure%registry 6 3% 13 6% 10% 8 2% 0.13 37 4%
Diabetes/Cardiovascular%registry 55 31% 65 31% 70 23% 64 18% 0.01 254 24%
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Table 5 (continued): PAM Level by Patient Characteristics 
 





Hospitalization+risk,+mean 7.8% 7.8% 6.0% 5.1% 0.00 6.4%
ED+Visits+(prior+12+months),+mean 2.1 2.4 2.3 2.0 0.00 2.2
>=7+Hospital+days+(prior+6+months) 3 2% 5 2% 6 2% 3 1% 0.54 +++++17+ 2%
Study"Characteristics
Intervention+Days+(prior+6+months),+mean 3.8 2.9 3.2 3.3 0.04 3.2
Engagement/Activation"Proxies
Significant+Support+System,+(7+missing)+(at+enrolment) 27 15% 45 21% 86 28% 98 28% 0.01 256 25%
Enroled+in+care+management 10 6% 18 8% 23 8% 20 6% 0.55 71 7%
PCP+visit+in+the+last+two+years 172 96% 195 92% 275 91% 311 90% 0.90 953 92%














Read+secure+messages+prior+12+months,+mean 2.0 2.1 2.5 2.3 0.76 2.2
MD+understanding:+v+good/excelent+(46+missing)+(at+enrolment) 84 47% 111 52% 149 49% 230 66% 0.01 574 55%
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Table 6: Annualized ED visit rate by Patient Characteristics 
 




Mean%Age 38.1 38.1 37.8 38.0 39.1 0.85 38.2
Gender,%male 57 18% 33 18% 26 11% 26 21% 22 11% 0.05 164 16%
Race
Hispanic 81 26% 31 17% 42 18% 20 16% 36 18% 210 20%
AfricanAAmerican 128 41% 90 49% 107 47% 62 51% 83 42% 470 45%
Other 39 13% 11 6% 16 7% 7 6% 17 9% 90 9%
White%nonAHispanic 62 20% 52 28% 63 28% 33 27% 61 31% 271 26%
Language,%Spanish 18 6% 9 5% 7 3% 0 0% 2 1% 0.01 36 3%
Home%Medical%Center
East%Bay 84 27% 48 26% 58 25% 23 19% 34 17% 247 24%
Napa/Solano 85 27% 55 30% 53 23% 24 20% 45 23% 262 25%
North%Valey 78 25% 43 23% 62 27% 49 40% 56 28% 288 28%
South%Sacramento 63 20% 38 21% 55 24% 26 21% 62 31% 244 23%
Health"Status"and"Conditions
Health%Status:%Very%good/excelent%(at%enrolment) 67 22% 42 23% 44 19% 18 15% 28 14% 0.20 199 19%
Current%Smoking%Status 76 25% 56 30% 68 30% 37 30% 52 26% 0.66 289 28%
Morbidly%obese 59 19% 33 18% 59 26% 28 23% 55 28% 0.13 234 22%
Disabled%(at%enrolment) 116 37% 65 35% 83 36% 51 42% 84 43% 0.72 399 38%
Pregnancy%(%of%females) 38 15% 26 17% 34 17% 13 14% 40 23% 0.32 151 17%
Depression%registry 93 30% 75 41% 85 37% 52 43% 94 48% 0.03 399 38%
Asthma%registry 73 24% 55 30% 75 33% 41 34% 77 39% 0.03 321 31%
Hypertention%registry 84 27% 60 33% 78 34% 50 41% 70 36% 0.19 342 33%
Heart%Failure%registry 7 2% 3 2% 9 4% 5 4% 13 7% 0.07 37 4%




















Table 6 (continued): Annualized ED visit rate by Patient Characteristics 
 




Hospitalization+risk,+mean 4.8% 4.9% 5.7% 6.9% 10.7% 0.00 6.4%
ED+Visits+prior+12+months
0 177 57% 84 46% 83 36% 15 12% 26 13% 385 37%
1A2 104 34% 74 40% 92 40% 68 56% 45 23% 383 37%
3A7 28 9% 24 13% 50 22% 34 28% 92 47% 228 22%
8+ 1 0% 2 1% 3 1% 5 4% 34 17% 45 4%
>=7+Hospital+days,+prior+6+months 7 2% 1 1% 1 0% 4 3% 4 2% 0.18 17 2%
Study"Characteristics
Intervention+days,+prior+six+months,+mean 3.0 3.1 3.1 3.3 3.8 0.25 3.2
Engagement/Activation"Proxies
PAM+Level,+first+survey
1st 46 15% 22 12% 39 17% 32 26% 40 20% 179 17%
2nd 58 19% 31 17% 49 21% 25 20% 49 25% 212 20%
3rd 96 31% 61 33% 61 27% 32 26% 53 27% 303 29%
4th 110 35% 70 38% 79 35% 33 27% 55 28% 347 33%
Significant+Suppt.+System+(at+enrolment) 93 30% 46 25% 49 21% 24 20% 44 22% 0.18 256 25%
Enroled+in+care+management 12 4% 12 7% 16 7% 9 7% 22 11% 0.05 71 7%
PCP+visit+in+the+last+two+years 275 89% 170 92% 209 92% 113 93% 186 94% 0.98 953 92%
PCP+changed+or+added+in+last+12+months 44 14% 27 15% 27 12% 19 16% 35 18% 0.62 152 15%
Read+secure+messages+prior+12+months,+mean 1.6 2.5 2.3 1.5 3.5 0.37 2.2




















Table 7: Unadjusted and Adjusted Cox Proportional Hazards Estimates: Time to ED Visits 
	  
Note: Comparisons use 90% 2-sided Wald robust CIs. Estimates centered at folow-up time of 68 days.  
1 significantly lower than Other Race 4 significantly lower than quintiles 4 and 5 
2 significantly lower than South Sacramento 5 significantly different from al other ED levels 













































































































































































Table 8: Adjusted ED Visit Hazard Ratios for Patients with last PAM score Level 1 versus Levels 2, 3, or 4  
by Race and PCP Change Status 
	  
***p<0.01 (for difference from 1.0)  **p<0.05  **p<0.10 
Model 1. Adjusted Multivariable Model with two, two-way interactions: PAMlevel1*race and PAMlevel*pcpchange.  
log(HR) = b1PAMlevel1+.+b2black + b3hispanic + b4other +..+b5pcpchange + 
         b6PAMlevel1·black+ b7PAMlevel1·hispanic + b8PAMlevel1·other + b9PAMlevel1·pcpchange 
Model 2. Adjusted Multivariable Model with one, two-way interaction: PAMlevel1*race.  
log(HR) = b1PAMlevel1+.+b2black + b3hispanic + b4other +.. + b5pcpchange + 
         b6PAMlevel1·black+ b7PAMlevel1·hispanic + b8PAMlevel1·other 
Model 3. Adjusted Multivariable Model with one, two-way interaction: PAMlevel1*pcpchange. 
log(HR) = b1PAMlevel1+.+b2black + b3hispanic + b4other +..+b5pcpchange + 
         b6PAMlevel1·pcpchange 
Model 4. Adjusted Multivariable Model with no interactions. 
log(HR) = b1PAMlevel1+.+b2black + b3hispanic + b4other +..+b5pcpchange 
HR HR HR
African*American 0.97 (0.85*1.11) 1.45*** (1.21*1.73) 1.06 (0.94*1.20)
Hispanic 0.99 (0.73*1.34) 1.47** (1.07*2.03) 1.03 (0.76*1.38)
Other 0.68*** (0.52*0.87) 1.01 (0.73*1.40) 0.73* (0.55*0.97)
WhiteAnon*Hispanic 0.83 (0.67*1.02) 1.23 (0.96*1.58) 0.88 (0.72*1.08)
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Importance: Motivational interviewing (MI) is a promising strategy for improving self-
management and behavior-sensitive outcomes, but it is unclear how to optimize its effectiveness. 
Objective: To examine the effect of an MI intervention, and variation in its intensity and type, on 
Patient Activation Measure (PAM) score changes among high-risk Medicaid patients cared for 
within an integrated health delivery system.  
Design: Retrospective cohort study from December 2009 through December 2011. 
Setting: Four medical centers within Kaiser Permanente Northern California (KPNC).  
Participants: We studied 915 high-risk Medicaid patients aged 18-62 years who had at least 10 
months of KPNC membership, lived at home, completed two or more PAM surveys, and were 
enroled in a MI program. High risk was defined as 2-8 emergency department (ED) visits or 
hospitalizations in the prior year or Diagnosis Cost Group (DxCG) score of >= 3. 
Main Outcome Measure: PAM score change. 
Results: Participants were typical of non-elderly, high-cost California Medicaid patients: mean 
age, 38 years; 85% female; 20% Hispanic; 46% African-American; 23% morbidly obese; 39% 
disabled. Participants completed a median (interquartile range) of 4 surveys (3-5), and the 
median (interquartile range) time from first to last PAM was 379 days (267-483). The mean first 
PAM score was 60.8 and the unadjusted change from first to last score was a clinicaly 
meaningful increase of 4.1 points (p<0.01). There was an average of 1.8 interventions/month 
before each PAM survey, 0.8 of which were coaching-style interventions. In multivariable 
regression, intervention quantity was unrelated to PAM score change. However, lower activation 
patients received the most interventions (PAM Level 1: 2.5/month; Level 2: 1.9/month; Level 3: 
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1.7/month; Level 4: 1.5/month; χ2 p<0.01) and improved their PAM scores the most between 
subsequent surveys (adjusted GEE PAM score change for Level 1 versus Level 4 at mean of 
interaction variables: 12.7 points; Level 2 versus Level 4: 11.9 points; Level 3 versus Level 4: 8.6 
points; al p<0.01). 
Conclusions and Relevance: MI interventions within a high-risk Medicaid population were 
associated with clinicaly meaningful improvements in patient activation, especialy among lower 
activation patients. Tailored MI intervention is a potentialy cost-effective approach for 
increasing patient activation. 
Introduction 
In 2006, 28% of Americans had two or more chronic conditions and this group accounted for 
almost 2/3rds of healthcare spending.4 People with five or more chronic conditions account for 
two-thirds of Medicare spending.4 Substantial efforts have been focused on identifying 
interventions within this high-risk population that can reduce future costs. 
Behavioral factors highly influence preventable deaths in the United States.53 Living wel with 
chronic disease requires significant self-care behavior, and evidence-based models of chronic 
disease care5,54-56 and federal policy57 have emphasized the importance of patient self-
management support.  
Motivational interviewing (MI) is a promising approach for improving self-care behaviors and 
“acknowledges the patient’s expertise into his or her own problems and empowers the patient to 
develop his or her own motivation.”16 Recent meta-analyses found that motivational interviewing, 
including brief intervention, improved self-efficacy, engagement, health behaviors, medication 
adherence, clinical markers, and quality of life.16-18 However, MI’s cost-effectiveness is less 
clear.19,20 Tailoring MI to patients with the greatest opportunity to improve their self-management 
skils could be a cost-effective strategy. 
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Measuring patient activation offers one potentialy innovative approach for targeting 
interventions to patients who can benefit the most, and for tracking the effectiveness of 
interventions in improving self-management.22 Patient activation is defined as a patient’s beliefs, 
knowledge, and skils for engaging in self-management behavior, and has been standardized 
through the 13-item Patient Activation Measure (PAM) (Appendix Table 14).36  
A variety of interventions have produced statisticaly and clinicaly significant changes in PAM 
scores including: brief intervention in a community health center;58 video motivational programs 
at senior centers;59 variants of the Chronic Disease Self-Management Program60 with an insured 
chronic disease population,61 a serious mental ilness population,62 and community-based diabetes 
population;63 a PAM-level tailored MI intervention in a disease management program,21 
participatory decision making in primary care practices,64 a tailored coaching intervention with 
heart failure patients,37 and web-based patient portals in primary care practices.65,66 
Despite the evidence that PAM scores can be improved and are associated with positive behaviors 
and clinical outcomes, it is unclear which interventions are most effective within different patient 
sub-groups. This study examines the extent to which variations in the intensity and content of a 
MI intervention in a high-utilizing, high chronic condition Medicaid population are associated 
with changes in patient activation. 
Methods 
Study design 
We conducted a retrospective cohort analysis of high-risk Medicaid patients enroled in a care 
management program implemented within an integrated health system. The program included 
assessment of patient activation using PAM surveys. Members were eligible if they were current 
Kaiser Permanente Northern California (KPNC) Medicaid members and: 
1. Had at least 10 months of Medicaid membership, and were not a Medicare member; 
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2. Were 18 through 62; 
3. Had two to eight ED visits or hospitalizations (excluding maternity) in the past twelve 
months or Diagnosis Cost Group (DxCG)41 prospective score of greater than 3 (4 for the 
first two enrolment groups); and,  
4. Were not a resident of a skiled nursing facility or hospice. 
Seting and Participants 
KPNC is a nonprofit, integrated healthcare delivery system providing comprehensive medical 
care to a diverse population of approximately 3.4 milion members. Distribution of patient 
demographic and socioeconomic factors is similar to that of the area population, except at the 
extremes of the income distribution.42 Al healthcare utilization is recorded within a 
comprehensive electronic medical record (EMR).  
Our study period begins at the point of completion of the first PAM survey, as early as December 
2009, and ends at the time of the patient's death or the patient’s last PAM survey (as late as 
December 2011). 
Our study period is the second phase of the care management program that began 22 months 
earlier. Care managers at four geographicaly defined service areas received lists of eligible 
Medicaid members in February 2008, August 2008, December 2008, June 2009, and December 
2009. Care managers enroled members in the program and completed a baseline patient 
assessment. Each service area had a dedicated team comprising one registered nurse, two 
licensed vocational nurses, and one licensed clinical social worker. Beginning in December 
2009, al care managers were trained in motivational interviewing and PAM administration. We 
considered members to be "PAM eligible" if they met the folowing criteria: 
1. Coded as "enroled" as of or at any time after December 1, 2009; or, 
2. Had >=1 intervention or atempted contact after December 1, 2009. 
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Care managers were instructed to atempt a PAM survey and conduct interventions at least every 
three months; however, this practice varied. As part of a quality improvement project, care 
managers administered the PAM by phone, occasionaly in person, and by mail before any care 
management intervention. Many care managers folowed up with members after a hospitalization 
or ED visit. Members received a $10 gift card for completing their first PAM survey.  
Sources of Analytic Variables 
We obtained age, gender, date of death, membership status, and home zip code from KPNC 
membership files; and obtained race/ethnicity, spoken language, smoking status, disability, and 
body mass index (BMI) from the EMR. Chronic conditions (e.g. hypertension, diabetes, asthma, 
heart failure, and depression) were identified using KPNC’s population care registry archives, 
which are updated quarterly. For socioeconomic status (SES), we obtained zip code-level poverty 
rate, median household income, high school graduation rate, and colege graduation rate from the 
United States Census Bureau’s 2007-2011 American Community Survey (ACS). We created a 
binary pregnancy variable if a member had any maternity hospital encounters from September 
2009 through June 2012. 
When atempting to enrol members, care managers asked about working status, informal (non-
health care provider) support system (“none”, “some”, or “significant”), and substance use; or, 
care managers assessed these three variables from a chart review. Care managers also 
administered a six-item intake questionnaire (Appendix Table 16) on experience of care and 
health status (with wording very similar to the first question on the SF-36 survey, with identical 
response categories).43  
Because members might have different PAM score changes based on the intensity of the pre-
PAM intervention, we created variables for the number of intervention days and for the elapsed 
time from first program intervention to the first PAM survey. 
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Clinical risk and utilization 
For clinical risk of hospitalization, we used a validated predictive model that incorporates age, 
gender, diagnostic information and key lab results.27 We used hospital days and ED visits as 
covariates to control for baseline differences among members, and ongoing utilization effects on 
PAM score change. We created variables for hospital days and ED visits for each member six 
months and one year before the start of each analysis interval. Hospitalizations, excluding 
maternity and psychiatry, and ED visits include care at KPNC and outside facilities and were 
colected from the EMR and outside biling records.  
Engagement proxies 
We used available data to create substitutes for patient activation that could influence 
improvements in activation. We included the intake questions “Does your physician understand 
your healthcare needs?” because prior research has shown that the PAM score was strongly 
associated with the Roter Doctor-patient Communication Scale.44 We included the support 
system assessment because of the possible overlap with the PAM construct. We also included 
whether a member was enroled in another care management program, had a primary care 
physician (PCP), had a visit with this PCP during the previous two years, and whether a member 
had the same PCP during the previous twelve months because prior research has demonstrated the 
link between PCP relationship and higher quality of care.45 The EMR includes a member portal, 
KP.org, which alows members to view components of their medical records, and to securely 
email with their physician. We created variables for the number of logins to KP.org, and number 
of sent and read messages.  
Outcome measure: change in PAM score 
Our primary outcome was the change in PAM score from one survey to the next. Score changes 
of four points have been associated with clinicaly meaningful behavior changes.21 Raw scores 
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for the PAM are calculated by assigning the values of 1-4 to responses from Disagree Strongly to 
Agree Strongly: patients are less likely to agree with each successive item in the survey. A Rasch 
scoring table converts curvilinear summated raw scores to linear, interval scores in the range of 0 
(lowest activation) to 100 (highest activation). Patients are classified into four activation levels 
(1=lowest activation, 4= highest activation) based on their scores (Appendix Figure 5).  The 
four-level structure was based on theory and psychometric properties from the PAM’s original 
development.23 This structure was confirmed in subsequent psychometric research as different 
versions of a three-level structure.46,47 
Intervention covariates 
The study tracked 90 different types of interventions (Appendix Table 19). Although the entire 
program was based on motivational interviewing, many of the interventions were referrals or care 
coordination that did not focus on patient capabilities or reducing cognitive barriers to self-
management. We defined four intervention categories (Appendix Table 20): 
1. Coaching (34% of total). Education and patient interaction indicating stronger 
motivational interviewing content. 
2. Non-coaching (36%). Care coordination, referral, and documentation of contacts. 
3. Emotional support (15%). Accessing emotional support was explicitly excluded from the 
original patient activation construct based on patient feedback.23 
4. Failed outreach (15%). Unsuccessful outreach atempt. 
Because almost 75% of the intervals between PAM surveys were less than four months 
(Appendix Table 15) we chose 120 days as the previous time period for creating intervention 
(coaching, non-coaching, and the total of both), emotional support, and failed outreach variables. 
To distinguish intervention intensity from intervention type, we also created a variable for the 
proportion of total interventions in the last 120 days that involved coaching. 
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Statistical analysis 
We analyzed patient characteristics for participants by only one versus multiple PAM surveys, by 
PAM Level, and by PAM score change quartile. To explore whether the interventions had 
differential impacts for patients at different PAM Levels, we calculated means for intervention 
variables by prior PAM Level and PAM change quartile. We tested for differences between 
covariates using χ2 tests for categorical variables and Kruskal-Walis tests for continuous 
variables, and used signed rank tests to compare first and last PAM scores. 
We used Generalized Estimating Equations (GEE)67 longitudinal data analysis to model PAM 
score change as a function of intervention intensity and characteristics controling for time (days 
since first PAM survey), demographics, health status, health conditions, clinical risk, prior 
utilization, study characteristics, last PAM Level, and engagement variables. GEE adjusts for 
repeated measurements on the same patient. We created a new dataset record for each folow up 
PAM survey and created new values for the folowing covariates that could have changed: 
intervention intensity, coaching intervention share, emotional support, failed outreach, clinical 
risk score, hospital days, ED visits, PCP, PCP visit, PCP change status, smoking, BMI, other care 
management, and chronic conditions. Each covariate was represented with its value in the month 
of the PAM survey, or its most recent value before that month.  
We included al variables with p-values lower than 0.25 from univariate analyses in the initial 
multivariable analyses. We kept variables in the models with p-values <0.05, if they caused 
significant confounding or they improved model fit. Race/ethnicity and gender were retained in 
the models to permit exploration of interactions with interventions variables. We categorized 
continuous variables or combined categories based on linear Wald hypothesis tests, and tested 
interactions between MI intervention variables and al other covariates. We checked and adjusted 
for multicolinearity and highly influential observations. 
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For sensitivity analyses, we tested a variety of final models with different combinations of 
covariates and specification of variables. For the approximately 1% of patients with missing 
values on some intake questions, we created a response level for “unknown,” and used linear 
Wald tests to decide whether to combine “unknown” with other categories. 
Analyses were conducted using SAS version 9.2 (SAS Institute Inc., Cary, North Carolina). The 
KPNC and Johns Hopkins Bloomberg School of Public Health IRBs approved this study. 
Results 
Study Participants 
Of the 2,973 members selected for the care management program, 1,254 did not enrol, were 
excluded by care managers or could not be reached (Figure 3). An additional 40 members were 
initialy enroled, but were dis-enroled before December 2009 and received no additional 
interventions. Of the 1,679 members who were PAM eligible, 1,041 completed at least one PAM 
survey, and 915 completed two or more and are the subject of our analysis (“repeat PAM 
cohort”). The Cronbach’s alpha (internal consistency) for the first PAM survey was 0.86. In the 
repeat PAM cohort, the median (interquartile range) folow-up time, from first to last PAM was 
379 days (267-483), and only 25 of the folow-up times were less than 90 days (2.7%). Repeat 
PAM cohort participants completed a median (interquartile range) of 4 surveys (3-5) and the 
median (interquartile range) of days between surveys was 95 (88-125) (Appendix Table 15). The 
overal study participation rate (multiple PAM completion/PAM eligible) was 54%.  
Findings on the representativeness of patients who completed at least one PAM survey compared 
to the ful eligible population are reported elsewhere (Table 1 and Table 2 in Manuscript 1). 
Repeat PAM cohort participants had a mean age of 38 years, and 20% were Hispanic, 46% were 
African-American and 26% were white (Table 9). Compared to patients who only completed one 
PAM, repeat PAM cohort participants were more likely to be African-American and less likely to 
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be of “Other” race, differed slightly by home medical center, and had fewer days from enrolment 
to first PAM (301 versus 368) (al p values≤0.05). There were no other significant differences. 
Thirty-eight percent of repeat PAM cohort participants were in the lowest two PAM Levels for 
their first survey (Table 9). Lower activation patients were older, less likely to work, and had 
lower health status, higher disability rates, higher depression rates, higher hospitalization risk, 
more time from enrolment to first PAM, more intervention days before first PAM, weaker 
support system, and lower perceived physician understanding of their healthcare needs (al p 
values≤0.01).  
PAM Score Change 
PAM scores increased over the entire course of the study (last PAM minus first PAM) by an 
average of 4.10 points (n=915, p<0.01) and median (interquartile range) of 2.8 (-4.8 – 12.6), with 
lower activation patients improving the most (first PAM Level 1: +10.4 points; Level 2: +9.0; 
Level 3: +4.5; Level 4: -2.6; al p-values <0.01). For patients who improved their PAM scores 
the most (PAM Change Quartile 4), the largest magnitude improvement on particular PAM 
questions, particularly for lower activation patients, tended to be higher difficulty ones such as 
“ability to maintain lifestyle changes,” “confidence in solving new problems,” and ”confidence in 
maintaining lifestyle changes during stress” (Appendix Table 21). 
In the analysis of al PAM score changes between subsequent surveys (n=2,855) being in a higher 
PAM change quartile was associated with higher total intervention rates, higher non-coaching 
interventions rates, and lower prior PAM Levels (Table 10, al p-values≤0.01). In the analysis of 
interventions by prior PAM Level (Table 11), within PAM Level 1, a higher coaching share was 
fairly consistently associated with higher PAM change quartile (p<0.01). Across al intervention 
types and al intervention subtypes (except for goals and patient meetings), care managers 
delivered more interventions to patients at lower prior PAM Levels (Total Interventions for prior 
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PAM Level 1: 2.5/month; Level 2: 1.9/month; Level 3: 1.7/month; Level 4: 1.5/month), 
particularly prior Level 1 (al p-values≤0.01). Other statisticaly significant differences were 
inconsistent in the direction of their relationship with PAM change quartile. 
In univariate regression, increasing total interventions by 2.25 (the interquartile range) was 
associated with a mere 0.4 more points of PAM score change (p=0.05) (Table 12). No other 
intervention variables were significant in univariate analysis. There was a significant univariate 
time trend of 1.0 points per 90 days (GEE regression of PAM Score on days since first PAM). 
In multivariable regression (Table 12 and Table 13), the non-intervention effects with the largest 
observed effects on PAM score change were prior PAM Level 1 (10.5 points higher than PAM 
Level 4 at 25th percentile of coaching share and 14.0 points higher at the 75th percentile), PAM 
Level 2 (10.4 and 12.7 points higher), prior PAM Level 3 (8.1 and 8.8 points higher), >=10 ED 
visits (3.1 points lower than <10), and “Excelent MD Understanding” (2.4 points higher than 
less than Excelent at 75th percentile of coaching share) (al p-values<0.01). Smaler significant 
effects (-2 to +2) in predictable directions were associated with age>=50, currently working, 
current smoker, and significant support system. There was no significant time trend in 
multivariable regression. 
None of the intervention variables, emotional support, or failed outreach had a significant 
association with PAM score change across al patients, but the coaching share variable had 
significant effects within patient subgroups. Holding al other variables constant, increasing the 
coaching share by 0.54 (the size of the interquartile range) among patients who reported 
“Excelent MD Understanding” was associated with 3.5 more points of PAM score change for a 
patient starting at Level 1 (p<0.01) and 2.3 more points for a Level 2 patient (p=0.05) (Table 13). 
Increasing the coaching proportion by 0.54 among patients with below “Excelent MD 
Understanding” was associated with 1.9 fewer points of score change (p=0.03). 
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Alternative variable transformations and model specifications produced similar coefficients for 
the significant effects. Using cluster deletion diagnostics, we found a large number of cases with 
high influence. We tested the model without these cases, and the direction, magnitude and 
significance of key variables did not change substantialy. Our reported results include al cases. 
Discussion 
We studied whether and how an MI intervention influenced changes in PAM scores over time for 
a high-risk Medicaid population. PAM scores improved by 4.1 points with improvement 
concentrated among patients starting at lower activation levels.  Activation improvements of this 
size have been associated with important improvements in patient behaviors.21 Lower activation 
patients also received more interventions of al types during the study. Our results suggest that 
MI can produce important improvements in patient activation in our high-risk Medicaid 
population.  
This study expands on previous literature by examining how natural variation in the application 
of a MI-based intervention influences PAM score changes in a high-risk, high-chronic condition, 
low-activation Medicaid population. Similar to other studies, we found larger increases in PAM 
scores for patients starting at lower activation levels.21,58,59 This could be caused by regression to 
the mean, or a ceiling effect, but it is encouraging that low activation patients seem to benefit 
most from intervention. Although our care managers were not trained to vary their intervention 
by initial activation level, they provided more interventions to patients at lower activation levels. 
This is consistent with another MI intervention that intentionaly tailored based on PAM,21 
suggesting that MI training, by its very nature, may lead care managers to tailor their work.  
Higher coaching content may be especialy important for initialy low activation patients who 
report strong MD understanding of their needs. “Excelent MD understanding” might magnify the 
effect of coaching interventions among low activation patients. Other studies have also found a 
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positive interaction of PAM and patient-physician understanding or satisfaction.44,68 There is 
some suggestive evidence that non-coaching interventions sustain activation beter among 
patients with initialy high activation and those who did not report “Excelent MD 
understanding.”  Possibly, patients who already have strong self-management skils develop and 
maintain their activation beter when a care manager explicitly solves problems (through referral 
and coordination) that the patient cannot solve alone. 
In another study depression was associated with lower PAM scores; we did not find that 
relationship in our population.61 Our patient population had much lower activation scores than a 
nationaly representative sample: 38% were in the lowest two activation levels compared to 21% 
nationaly, and only 33% were in the highest level compared to 41% nationaly.49  
A central question for operational and clinical leaders is whether PAM or other patient-centered 
assessments provide a useful guide to intensity or content of care management interventions. 
Does PAM help identify which high-risk patients need intervention and which interventions wil 
work? From the Physician Group Practice Demonstration (PGPD)50 to Accountable Care 
Organizations (ACOs), federal policy aims to give integrated delivery systems the opportunity 
and incentive to improve patient wel-being at the lowest per capita cost. To make care 
management cost-effective, patients at lower levels of activation might receive higher intensity 
interventions aimed at building a belief that what they do maters for their health, and patients at 
higher levels of activation might receive lower intensity, and less expensive interventions, aimed 
at assisting them in staying on track during times of stress. A large quasi-experimental study has 
provided evidence that this tailoring approach works to improve outcomes and reduce utilization 
for an employed population.21 A randomized study of a diabetes peer-coaching intervention 
found that the intervention only had impact among patients with low or moderate baseline self-
management skils; patients with high self-management skils improved equaly with and without 
intervention.51 
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The results of this study need to be interpreted within in the limits of the study design. As an 
observational study, we are subject to unmeasured confounding and cannot determine causality. 
However, PAM does not usualy improve without intervention: with one exception,61 the control 
group in randomized studies has not improved by clinicaly meaningful levels.21,37,62,63,66 Our 
finding of a strong association between prior PAM Level and PAM score change could also be 
caused by the systematic delivery of more interventions to low activation patients, but our study 
design makes it chalenging to separate the causal effects of “last PAM level” and “number of 
interventions.” Our study population is reasonably representative of the high-risk Medicaid 
group from which it was drawn. The apparently lower clinical risk in our study population 
compared to patients who did not complete at least one PAM survey is probably related to the 
underlying study design and not to biased selection. Possibly because of language barriers, a 
disproportionately smal, and possibly lower risk, group of Hispanic patients completed at least 
one PAM. 
We found a clinicaly meaningful improvement in activation from an MI intervention in a high 
utilizing Medicaid population. Care managers delivered more interventions to low activation 
patients. Activation improved the most among patients starting with low activation. Randomized 
studies of a PAM-tailored MI intervention are needed to develop evidence-based cost-effective 
strategies for further improving self-management behavior. 
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2,973 potentialy eligible 
Medi-Cal enrolees invited 
into intervention 
PAM ineligible 
• 1,254 did not enrol (declined, excluded by care managers or 
could not be reached) 
• 40 disenroled <12/1/09 (start of PAM) and had 0 documented 
interventions or contact atempts >=12/1/09 
638 did not complete a PAM survey 
126 completed only one PAM survey 
1,679 Enroled in 
program (“PAM 
eligible” 
1,041 completed at 
least one PAM survey 
(“PAM cohort”) 
915 completed at least 
two PAM surveys 
(“repeat PAM cohort”) 
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Table 9: Patient Characteristics by Number of PAMs and first PAM Score Level, for patients with multiple surveys 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables.  
Socio%Demographic
Mean%Age 36.8 38.4 %%38.2% 0.13 40.5 39.7 38.5 36.5 0.00
Gender,%female 99 79%%%778%85% 877%% 84% 0.46 136 83%%%150%82% %231%87%%%261%86% 0.96
Race
White%nonBHispanic 30 24%%%241%26% 271%% 26% 51 31% 48 26% 72 27% 70 23%
AfricanBAmerican 48 38%%%422%46% 470%% 45% 78 48% 75 41% 125 47% 144 48%
Hispanic 29 23%%%181%20% 210%% 20% 25 15% 40 22% 44 16% 72 24%
Other 19 15% %%%71% 8% 90%%% 9% 9 6% 19 10% 26 10% 17 6%
Language,%Spanish 3 2% %%%33% 4% 36%%% 3% 0.49 2 1% 8 4% 10 4% 13 4% 0.35
Home%Medical%Center
East%Bay 29 23% 218% 24% 247%% 24% 23 14% 34 19% 63 24% 98 32%
Napa/Solano 20 16% 242% 26% 262%% 25% 33 20% 49 27% 76 28% 84 28%
North%Valey 42 33% 246% 27% 288%% 28% 71 44% 55 30% 62 23% 58 19%
South%Sacramento 35 28% 209% 23% 244%% 23% 36 22% 44 24% 66 25% 63 21%



























Colege%graduation%rate(in%home%zip) 23.4 23.5 23.5 0.59 23.1 23.9 23.2 23.8 0.90
Ful%or%partBtime%work%(at%enrolment) 35 28%%%199%22% 234%% 22% 0.18 20 12% 33 18% 65 24% 81 27% 0.01
Health0Status0and0Conditions
Health%Status%(at%enrolment)
Missing 5 4% 6 1% 11%%% 1% 0.00 0 0% 1 1% 4 1% 1 0% 0.21
Poor 15 12% 108 12% 123%% 12% 34 21% 27 15% 28 10% 19 6%
Fair 34 27% 274 30% 308%% 30% 70 43% 59 32% 67 25% 78 26%
Good 45 36% 355 39% 400%% 38% 45 28% 72 40% 120 45% 118 39%
Very%good 16 13% 119 13% 135%% 13% 10 6% 16 9% 38 14% 55 18%
Excelent 11 9% 53 6% 64%%% 6% 4 2% 7 4% 10 4% 32 11%
0.000.71
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Table 9 (continued) Patient Characteristics by Number of PAMs and first PAM Score Level, for patients with multiple surveys  
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables.  
Health'Status'and'Conditions'(cont.)























BMI(category,(morbidly(obese 24 19% 210 23% 234(( 22% 0.39 42 26% 47 26% 58 22% 63 21% 0.57
Substance(abuse(at(enrolment) 15 12% 112 12% 127(( 12% 0.92 29 18% 26 14% 24 9% 33 11% 0.06
Disabled(at(enrolment) 41 33%((358(39% 399(( 38% 0.26 85 52% 83 46% 100 37% 90 30% 0.00
Depression 43 34%((356(39% 399(( 38% 0.42 91 56% 80 44% 93 35% 92 30% 0.00
Asthma 34 27%((287(31% 321(( 31% 0.41 53 33% 63 35% 77 29% 94 31% 0.74
Hypertention(registry 38 30%((304(33% 342(( 33% 0.57 70 43% 65 36% 82 31% 87 29% 0.06
Heart(Failure(registry 3 2% (((34( 4% 37((( 4% 0.46 6 4% 12 7% 9 3% 7 2% 0.12
Diabetes/Cardiovascular 28 22%((226(25% 254(( 24% 0.60 49 30% 57 31% 64 24% 56 18% 0.02
Clinical'Risk'and'utilization
Hospitalization(risk 6.6% 6.3% 6.4% 0.14 7.9% 7.4% 6.2% 5.0% 0.00
ED(visits(prior(180(days,(annualized 2.1(( 2.3(( 2.3(( 0.18 2.2 2.4 2.5 2.1 0.02
Hosp.(days(prior(180(days,(annualized ((0.9( ((0.8( (((0.8( 0.56 0.8 0.8 0.9 0.6 0.11
Study'Characteristics
Days(from(enrolment(to(first(PAM 368 301 309 0.04 375 332 294 249 0.00
Intervention(days(before(first(PAM 8.0 8.1 8.1 0.77 10.6 7.7 7.3 7.6 0.00
List(date
FebV08 31 25% 186 20% 217 21% 43 26% 44 24% 50 19% 49 16%
AugV08 24 19% 204 22% 228 22% 37 23% 35 19% 60 22% 72 24%
DecV08 21 17% 183 20% 204 20% 27 17% 34 19% 61 23% 61 20%
JunV09 23 18% 150 16% 173 17% 29 18% 29 16% 41 15% 51 17%
DecV09 27 21% 192 21% 219 21% 27 17% 40 22% 55 21% 70 23%
Engagement/Activation'Proxies
PAM(Score 63.0 60.8 61.0 0.18 41.7 50.2 60.0 78.0 0.00
Total(PAM(Surveys 1.0 4.1 3.7 0.00 4.1 4.1 4.1 4.2 0.79
0.360.67
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Table 9 (continued) Patient Characteristics by Number of PAMs and first PAM Score Level, for patients with multiple surveys  
 




none 11 9% 51 6% 62 6% 16 10% 15 8% 11 4% 9 3%
some 80 63% 636 70% 716 69% 122 75% 129 71% 176 66% 209 69%
significant 31 25% 225 25% 256 25% 24 15% 38 21% 78 29% 85 28%
























PCP'visit'in'the'last'two'years 111 88%''842'92% 953 92% 0.67 157 96% 169 93% 246 92% 270 89% 0.89
PCP'changed/added/none'last'12'mos. 18 14%''134'15% 152 15% 0.92 21 13% 24 13% 34 13% 55 18% 0.28
Sent'messages'in'last'12'mos. 1.4 2.2 2.1 0.47 2.1 1.9 2.6 2.1 1.00
MD'understanding'of'needs'(at'enrol)
Unknown 9 7% 37 4% 46''' 4% 0.12 5 3% 4 2% 15 6% 13 4% 0.31
poor 8 6% 33 4% 41''' 4% 8 5% 6 3% 13 5% 6 2%
fair 9 7% 90 10% 99''' 10% 28 17% 13 7% 27 10% 22 7%
good 34 27% 247 27% 281'' 27% 46 28% 59 32% 83 31% 59 19%
very'good 31 25% 233 25% 264'' 25% 43 26% 54 30% 59 22% 77 25%
excelent 35 28% 275 30% 310'' 30% 33 20% 46 25% 70 26% 126 42%
0.000.53
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Table 10: Patient Characteristics by Quartile of PAM Score Change from Last PAM Survey 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables.  
P"value
Socio,Demographic
Mean%Age%(as%of%month%of%first%PAM%survey) 40.0 38.7 39.6 40.4 0.05 39.6
Gender,%female 609 85% 671 85% 537 84% 608 86% 1.00 2425 85%
Race
White%nonIHispanic 203 28% 228 29% 185 29% 191 27% 807 28%
AfricanIAmerican 331 46% 350 44% 281 44% 325 46% 1287 45%
Hispanic 128 18% 140 18% 116 18% 132 19% 516 18%
Other 53 7% 74 9% 55 9% 63 9% 245 9%
Language,%Spanish 32 4% 22 3% 20 3% 25 4% 0.34 99 3%
Home%Medical%Center
East%Bay 154 22% 168 21% 145 23% 143 20% 610 21%
Napa/Solano 223 31% 266 34% 223 35% 213 30% 925 32%
North%Valey 197 28% 228 29% 166 26% 218 31% 809 28%
South%Sacramento 141 20% 130 16% 103 16% 137 19% 511 18%
















Colege%graduation%rate(in%home%zip) 23.5 24.4 24.1 23.1 0.12 23.8
Ful%or%partItime%work%(at%enrolment) 133 19% 167 21% 108 17% 159 22% 0.11 567 20%
Health"Status"and"Conditions
Health%Status%(at%enrolment)
Missing 3 0% 3 0% 3 0% 5 1% 0.82 14 0%
Poor 87 12% 85 11% 91 14% 99 14% 362 13%
Fair 216 30% 244 31% 223 35% 207 29% 890 31%
Good 262 37% 306 39% 204 32% 272 38% 1044 37%
Very%good 93 13% 119 15% 87 14% 79 11% 378 13%
Excelent 54 8% 35 4% 29 5% 49 7% 167 6%
0.01
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BMI(category,(morbidly(obese 172 24% 199 25% 163 26% 177 25% 0.95 711 25%
Substance(abuse((at(enrolment) 97 14% 109 14% 85 13% 99 14% 0.99 390 14%
Disabled(at(enrolment) 309 43% 364 46% 273 43% 304 43% 0.75 1250 44%
Depression 299 42% 326 41% 275 43% 303 43% 0.94 1203 42%
Asthma 236 33% 272 34% 234 37% 229 32% 0.51 971 34%
Hypertention(registry 260 36% 288 36% 258 41% 266 37% 0.56 1072 38%
Heart(Failure(registry 34 5% 28 4% 27 4% 38 5% 0.39 127 4%
Diabetes/Cardiovascular 191 27% 208 26% 189 30% 199 28% 0.63 787 28%
Clinical"Risk"and"utilization
Hospitalization(risk 7.3% 7.3% 7.8% 7.6% 0.74 7.5%
ED(visits(prior(180(days,(annualized 2.8 2.1 2.1 2.1 0.33 2.3
Hospital(days(prior(180(days,(annualized 1.2 0.9 1.3 1.1 0.60 1.1
Care"Manager"Contacts"(monthly"avg."last"120"days)
Total(interventions 1.66 1.65 2.00 1.85 0.01 1.78
Coaching(interventions 0.74 0.75 0.84 0.84 0.62 0.79
Diagnosis 0.16 0.17 0.18 0.19 0.11 0.17
Goals 0.10 0.09 0.09 0.10 0.44 0.09
Diet 0.08 0.08 0.09 0.10 0.09 0.09
Medication(Reconciliation 0.08 0.08 0.09 0.09 0.66 0.08
Benefits 0.08 0.07 0.07 0.08 0.63 0.07
NonXCoaching(Interventions 0.92 0.89 1.16 1.01 0.00 0.99
Confirm(Appointment 0.16 0.15 0.19 0.18 0.54 0.17
Contact(PCP 0.12 0.12 0.16 0.12 0.00 0.13
Patient(Meeting 0.10 0.09 0.12 0.10 0.04 0.10
Refer(to(PCP 0.07 0.07 0.11 0.09 0.01 0.08
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Table 10 (continued): Patient Characteristics by Quartile of PAM Score Change from Last PAM Survey 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables. 
P"value
Care"Manager"Contacts"(continued)
Coaching)share)of)total)interventions 0.36 0.33 0.33 0.35 0.38 0.34
Emotional)support 0.34 0.35 0.41 0.37 0.02 0.37
Failed)outreach 0.16 0.14 0.16 0.16 0.35 0.16
Study"Characteristics
Days)from)enrolments)to)first)PAM 284 276 300 292 0.45 287
Intervention)days)before)first)PAM 8.4 8.6 9.5 8.7 0.53 8.8
Engagement/Activation"Proxies
Last)PAM)score)Level
1 20 3% 121 15% 156 24% 135 19% )))432) 15%
2 52 7% 149 19% 120 19% 172 24% )))493) 17%
3 204 29% 233 29% 178 28% 237 33% )))852) 30%
4 439 61% 289 36% 183 29% 167 23% )1,078) 38%
Days)from)first)PAM)to)this)PAM)survey 278 275 254 262 0.00 268
Days)from)last)PAM)to)this)PAM)survey 123 116 112 123 0.02 119















Support)System,)significant)(at)enrolment) 175 24% 202 26% 154 24% 186 26% 0.87 )))717) 25%
PCP)changed,)added,)or)none)in)last)12)mos. 112 16% 123 16% 112 18% 128 18% 0.55 )))475) 17%
Sent)messages)within)12)months)before)first)PAM 2.4 2.2 2.1 2.1 0.91 2.2
MD)understanding)of)needs)(at)enrolment)
Unknown 29 4% 30 4% 29 5% 29 4% 0.92 117 4%
poor 20 3% 21 3% 21 3% 24 3% 86 3%
fair 71 10% 81 10% 75 12% 68 10% 295 10%
good 180 25% 200 25% 165 26% 186 26% 731 26%
very)good 174 24% 247 31% 155 24% 173 24% 749 26%
excelent 241 34% 213 27% 192 30% 231 32% 877 31%
0.07
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Table 11: Mean Interventions Rates by Category and Detail Type, by Last PAM Survey 
Level, and by Quartile of PAM Score Change (n=2,855) 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables. 


















Last)PAM)Level)1 N=20 N=121 N=156 N=135 0.00 N=432
Total$interventions 3.49 2.14$ 2.68$ 2.52$ 0.37 2.52$
Coaching$interventions 1.04 0.97$ 1.09$ 1.16$ 0.47 1.08$
Diagnosis 0.29 0.25$ 0.28$ 0.30$ 0.32 0.28$
Goals 0.04 0.08$ 0.13$ 0.13$ 0.25 0.11$
Diet 0.08 0.11$ 0.10$ 0.15$ 0.19 0.12$
Medication$Reconciliation 0.09 0.12$ 0.14$ 0.14$ 0.41 0.13$
Benefits 0.11 0.10$ 0.07$ 0.09$ 0.30 0.09$
Non%coaching$interventions 2.45 1.17$ 1.58$ 1.37$ 0.15 1.44$
Confirm$Appointment 0.29 0.21$ 0.31$ 0.26$ 0.06 0.27$
Contact$PCP 0.25 0.18$ 0.25$ 0.20$ 0.24 0.21$
Patient)Meeting 0.18 0.07) 0.16) 0.13) 0.01 0.13)
Refer$to$PCP 0.21 0.10$ 0.13$ 0.08$ 0.37 0.11$
Coaching)share)of)total 0.25 0.40) 0.34) 0.44) 0.00 0.38)
Emotional$support 0.66 0.45$ 0.56$ 0.52$ 0.24 0.52$
Failed$outreach 0.24 0.19$ 0.18$ 0.20$ 0.44 0.19$
Last)PAM)Level)2 N=52 N=149 N=120 N=172 0.00 N=493
Total)interventions 2.47 1.67 1.70 2.00 0.05 1.88)
Coaching)interventions 1.09 0.76 0.67 0.92 0.02 0.83)
Diagnosis 0.23 0.15 0.14 0.22 0.02 0.18)
Goals 0.14 0.10 0.08 0.10 0.24 0.10$
Diet 0.12 0.09 0.07 0.11 0.40 0.10$
Medication$Reconciliation 0.14 0.11 0.08 0.08 0.13 0.09$
Benefits 0.09 0.06 0.06 0.10 0.01 0.08)
Non%coaching$interventions 1.38 0.91 1.03 1.08 0.24 1.05$
Confirm$Appointment 0.22 0.17 0.15 0.18 0.75 0.17$
Contact$PCP 0.25 0.12 0.15 0.14 0.56 0.15$
Patient$Meeting 0.12 0.11 0.10 0.11 0.87 0.11$
Refer$to$PCP 0.08 0.07 0.10 0.10 0.69 0.09$
Coaching)share)of)total 0.40 0.31 0.27 0.38 0.01 0.34)
Emotional$support 0.40 0.34 0.37 0.39 0.57 0.37$
Failed)outreach 0.27 0.15 0.15 0.18 0.04 0.17)
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Table 11 (continued): Mean Interventions Rates by Category and Detail Type, by Last 
PAM Survey Level, and by Quartile of PAM Score Change 
 
Note: Kruskal-Walis test for continuous variables, and chi-square test for categorical variables. 














Last$PAM$Level$3 N=204 N=233 N=178 N=237 0.25 N=852
Total&interventions 1.88 1.45 1.80 1.51 0.02 1.65&
Coaching$interventions 0.81 0.67 0.83 0.67 0.08 0.74$
Diagnosis 0.19 0.16 0.16 0.14 0.10 0.16$
Goals 0.10 0.08 0.08 0.09 0.77 0.09$
Diet 0.08 0.06 0.10 0.07 0.11 0.07$
Medication$Reconciliation 0.09 0.07 0.07 0.09 0.63 0.08$
Benefits 0.08 0.08 0.09 0.07 0.55 0.08$
Non%coaching$interventions 1.07 0.81 0.97 0.84 0.13 0.92$
Confirm$Appointment 0.19 0.15 0.13 0.16 0.16 0.16$
Contact&PCP 0.15 0.09 0.11 0.08 0.00 0.11&
Patient$Meeting 0.12 0.11 0.12 0.09 0.14 0.11$
Refer$to$PCP 0.09 0.05 0.11 0.06 0.04 0.08$
Coaching$share$of$total 0.35 0.31 0.35 0.31 0.35 0.33$
Emotional$support 0.39 0.32 0.36 0.30 0.18 0.34$





Last&PAM&Level&4 N=439 N=289 N=183 N=167 0.00 N=1078
Total$interventions 1.38 1.56 1.81 1.63 0.56 1.54$
Coaching$interventions 0.65 0.73 0.75 0.73 0.73 0.70$
Diagnosis 0.13 0.15 0.16 0.15 0.86 0.15$
Goals 0.10 0.10 0.09 0.10 0.77 0.10$
Diet 0.07 0.09 0.10 0.08 0.23 0.08$
Medication$Reconciliation 0.06 0.06 0.07 0.05 0.45 0.06$
Benefits 0.07 0.06 0.06 0.06 0.36 0.07$
Non%coaching$interventions 0.72 0.83 1.06 0.90 0.18 0.84$
Confirm$Appointment 0.13 0.13 0.17 0.13 0.76 0.14$
Contact$PCP 0.09 0.11 0.15 0.09 0.06 0.11$
Patient$Meeting 0.08 0.08 0.11 0.10 0.35 0.09$
Refer$to$PCP 0.06 0.08 0.10 0.11 0.16 0.08$
Coaching$share$of$total 0.36 0.34 0.34 0.30 0.27 0.34$
Emotional$support 0.30 0.34 0.35 0.31 0.29 0.32$
Failed$outreach 0.12 0.13 0.18 0.15 0.26 0.14$
 77 
Table 11 (continued): Mean Interventions Rates by Category and Detail Type, by Last 
PAM Survey Level, and by Quartile of PAM Score Change 
 


















Al$Last$PAM$Levels N=715 N=792 N=637 N=711 N=2855
Total(interventions 1.66 1.65 2.00 1.85 0.00 1.78(
Coaching(Interventions 0.74 0.75 0.84 0.84 0.00 0.79(
Diagnosis 0.16 0.17 0.18 0.19 0.00 0.17(
Goals 0.10 0.09 0.09 0.10 0.69 0.09$
Diet 0.08 0.08 0.09 0.10 0.00 0.09(
Medication(Reconciliation 0.08 0.08 0.09 0.09 0.00 0.08(
Benefits 0.08 0.07 0.07 0.08 0.01 0.07(
NonKcoaching(interventions 0.92 0.89 1.16 1.01 0.00 0.99(
Confirm(Appointment 0.16 0.15 0.19 0.18 0.00 0.17(
Contact(PCP 0.12 0.12 0.16 0.12 0.00 0.13(
Patient$Meeting 0.10 0.09 0.12 0.10 0.16 0.10$
Refer(to(PCP 0.07 0.07 0.11 0.09 0.00 0.08(
Coaching(share(of(total 0.36 0.33 0.33 0.35 0.01 0.34(
Emotional(support 0.34 0.35 0.41 0.37 0.00 0.37(
Failed(outreach 0.16 0.14 0.16 0.16 0.00 0.16(
 78 
Table 12: Unadjusted and Adjusted Generalized Estimating Equations Results Modeling 






504–465 !0.54 (!1.25−0.18 ) !1.07* (!2.08−!0.07)
Gender,4ref=male 0.51 (!0.36−1.39 ) 0.32 (!0.83− 1.48)
Race,+ref=White
Hispanic 0.25 (!0.75−1.24 ) 0.79 (!0.50− 2.08)
African!American 0.26 (!0.45−0.98 ) 0.54 (!0.49− 1.56)
Other 0.28 (!0.71−1.26 ) 0.34 (!1.18− 1.86)
South4Sacramento !0.23 (!1.07−0.61 ) !1.23* (!2.32−!0.14)
Part4or4ful!time 0.77 (!0.04−1.59 ) 1.79** ( 0.71− 2.88)
Current4Smoker !1.13** ( !1.88−!0.38) !1.28** (!2.23−!0.33)
>=10 !2.59* ( !4.61−!0.58) !3.14** (!5.42−!0.87)
Increase4of42.254(IQ4range) 0.36* ( 0.00−0.72 ) 0.19 (!0.22− 0.60)
Increase4of40.54(IQ4range) !0.19 (!1.00−0.63 )
1 11.83**33 (10.38−13.27)
2 11.21**33 ( 9.68−12.73)













Significant 0.39 (!0.38−1.16 ) 1.95** ( 0.98− 2.92)







Table 13: PAM Score Change at the 25th and 75th Percentiles of Coaching Proportion by Last PAM Level and MD Understanding of 
Patient Healthcare Needs (Patients=915, N=2,855) 
 
Note: Al comparisons use 95% two-sided Wald confidence intervals. Analysis based on ful GEE model with two-way interactions between 
“Coaching Proportion” and “Last PAM Level,” and between “Coaching Proportion” and “MD Understanding.” 
 ** different from 0, p<0.01 33different from Level 3, p<0.01 ##different from Unknown, Poor-VG at p<0.01 
 * different from 0, p<0.05 3different from Level 3, p<0.05 
    44different from Level 4, p<0.01 
 ++ different between 75th and 25th percentile of coach proportion, p<0.01 






Unknown,'Poor*Very'Good 10.5* (8.3−12.6) 12.1** (10.1−14.1)
Excelent 10.9* (8.0−13.9)++ 14.5**## (12.1−16.9)
Unknown,'Poor*Very'Good 10.4** (8.2−12.6) 10.9** (8.8−12.9)
Excelent 10.9** (8.0−13.8) + 13.2**## (10.8−15.6)
Unknown,'Poor*Very'Good 8.1** (6.0−10.1) 7.0** (5.0−8.9 )
Excelent 8.5** (5.7−11.4) 9.3**## (7.1−11.6)
Unknown,'Poor*Very'Good 0.0 + *1.9* (*3.5−*0.2)






















Conclusion:	  Implications	  for	  policy	  and	  practice	  
A central goal of accountable providers (ACOs and HMOs), particularly with ACA 
implementation, is to identify high-cost patient sub-groups where the delivery system can take an 
action that wil reduce costs or improve outcomes. The key for making this approach cost-
efective is to find effective interventions and only use them in subgroups where they would have 
the greatest impact. We hypothesized that 1) PAM can be used to gauge the intensity or style of 
intervention a person needs; and 2) MI could be a promising intervention for high-cost or 
multiple chronic disease patients. MI alters stereotypes about what a person needs away from 
their diseases, barriers, and failures and toward what maters most to them as a person. Then, the 
care system’s job is to provide the support to achieve their health-related goals.  
The results of this project provide the folowing insights about the utility of this approach: 
1. The PAM is probably most useful for targeting outcomes that are patient behavior 
sensitive. We found stronger and more consistent evidence that low patient activation is 
correlated with higher utilization risk for ED visits rather than for hospitalizations 
particularly within a relatively short time frame. Research has consistently found that ED 
visits are more preventable than hospitalizations.2 
2. Motivational interviewing appears to improve self-management capabilities and should 
be considered for any care management program where patient behavior change is 
important. The overal intervention was associated with clinicaly meaningful PAM 
score improvements, particularly among patients who started with low self-management 
skils. This suggests that motivational interviewing could be an important strategy for 
health systems aiming to improve self-management behaviors.  
3. People with the lowest initial activation seemed to improve their activation the most from 
the intervention. Rather than giving up on those who start with low self-management 
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capabilities, this group might benefit from the most care manager atention (which they 
did actualy receive during this intervention).  
4. PAM should be supplemented by other variables that are predictive of important 
outcomes. In this study, hospitalization risk, prior utilization, demographic factors, and 
engagement variables had a role in predicting future utilization (although with varying 
importance for hospitalization and ED visit risk). In deciding where to concentrate care 
management resources, a delivery system might focus on patients with higher future 
predicted utilization risk and lower PAM scores. 
5. Patient activation levels and MI interventions seem to be more important among some 
groups of patients, but our results do not provide a clear enough picture to guide action. 
The PAM seems to be variably predictive of future utilization among subgroups of 
patients, and MI seems to have variable impact on PAM score change within subgroups. 
Low activation increased hospitalization risk among patients with significant support 
systems, but did not among those with no or some support. Low activation increased ED 
visit risk among patients without a stable PCP. A higher share of coaching interventions 
was associated with larger PAM score improvements among low activation patients who 
reported “Excelent” physician understanding of their needs. Although some of these 
subgroup findings are intuitive, they suggest that patient activation and motivational 
interviewing have variable effects and that this variation might be explained by variables 
that we could not include in our study. 
6. Groupings of PAM Levels might be the best guide for targeting interventions. Our 
findings in the three manuscripts suggest thresholds for PAM effects. For example, in 
predicting hospitalizations, PAM Levels 1, 2, and 3 could not be statisticaly 
distinguished; hospitalization risk for patients with “Significant” support systems only 
decreased at Level 4. ED visit risk reduction could not be statisticaly distinguished 
among PAM Levels 2, 3, and 4; ED visit risk for subgroups was only higher at Level 1. 
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In Manuscript 3, PAM score changes could not be distinguished between Levels 1 and 2.  
These observations could be artifacts of our sample sizes and selection of variables, but 
they warrant additional exploration in practice and research. 
The folowing issues were not resolved by this study, and require further research: 
1. How should MI strategies be tailored for maximum cost-effectiveness? This study found 
suggestive evidence that a higher share of coaching interventions led to larger PAM score 
improvements for some low activation patients, and that overal lower activation patients 
seem to improve PAM scores the most. We also found that low activation patients with 
an unstable PCP connection had a higher risk of future ED visits. However, our study 
design does not alow us to make strong conclusions on causation; these findings are 
primarily hypothesis generating. We need more rigorous evaluation of which subgroups 
of patients benefit from MI, and which do wel with no or minimal intervention. It is also 
important to study whether MI could be effectively tailored to subgroups without the 
expense of measuring PAM.  
2. What variables might be substitutes or complements to PAM for subgrouping patients for 
skil-based or MI interventions?  Although this study atempted to distinguish the effects 
of PAM from potential substitutes, we were not able to directly measure socioeconomic 
status (income and education) or, more importantly, health literacy. Research has found a 
strong interaction between a patient’s health literacy and participatory decision-making 
with their physicians.69 A recent careful study found that although health literacy and 
PAM were weakly correlated, they made independent contributions to important health 
outcomes and were both good targets for intervention.70 These authors suggest health 
literacy measurement could guide skil-based intervention, and patient activation 
measurement could guide motivational interventions. Non-survey alternatives to PAM 
might also include medication adherence, missed appointments, or other “effective” 
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engagement measures. In exploring engagement substitutes for PAM, research wil need 
to focus on disentangling what appears to be higher engagement from simply a person 
needing more healthcare services. 
3. How should a provider system ensure that it has effectively implemented MI?  MI can be 
difficult to implement consistently, particularly because it chalenges many of the shared 
beliefs of healthcare professionals. Anecdotaly, a number of care managers in the 
intervention we studied were very uncomfortable with the MI approach, feeling that it did 
not address patients’ needs or was contrary to their clinical duty.  How important is 





Additional Methods Information 
Timing of “First Intervention” and the PAM survey 
Because four lists were sent to care managers before the program started using the PAM survey, 
almost half of the 1,041 study participants received their first care management interventions 
before 12/1/2009. Appendix Figure 4 below shows the entire duration of the study from January 
2008 through the end in December 2012. The five graphs show the frequency of “first 
interventions” and first PAM surveys by month. For the purposes of the study, “first 
intervention” is the earlier of the members’ coded enrolment date in the study and the first 
intervention coded by care managers in MediTrak. Care managers could have been intervening 
with a member for a year or more before they coded “enrolment” in MediTrak. 
Data sources 
The data for this study was built from six sources:  
1. Underlying study data. This information was colected as part of the administration of 
the study and includes the list of members selected, dates and types of interventions by 
care managers, and results of the baseline survey completed at time of enrolment. 
2. Utilization Datamart. KPNC creates inpatient and outpatient utilization analytical files 
for management reporting from the Kaiser Permanente Health Connect (KPHC) EMR 
system and from the smal number of outside claims. 
3. Membership Datamart. KPNC creates membership analytical files comprising al 
membership periods from al payers. 
4. Clarity. For variables measuring patient use of our electronic medical record system, and 
secure messages to and from members, we extracted information directly from the 
reporting extract from KPHC.  
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5. Population Management Tool (PMT). TPMG maintains population registries to conduct 
population in care management programs. The extract from PMT includes registry, care 
management, and PCP information. 
6. Division of Research. The KPNC Division of Research conducts studies focused on 
racial and ethnic disparities. They are experts at combining information on race and 
ethnicity from membership files and Clarity. Using their standard methods, they created 
race, ethnicity, and spoken language variables for our study data set. 
7. RHO2 Hospitalization risk. Hospital risk score is calculated for almost every month for 
al KPNC members and available on the KPNC mainframe. 
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Appendix Tables and Figures 
Appendix Table 14: 13-item PAM instrument and Mean Item Responses by First PAM 
Survey Score Level36 
 
Note:  
• Responses coded as 1=Disagree Strongly, 2=Disagree, 3=Agree, 4=Agree Strongly  



























associated&with&my&health&condition& 2.62 2.88 3.14 3.70 3.19




myself& 2.65 3.03 3.29 3.70 3.27
6
I&am&confident&I&can&tel&my&health&care&provider&
concerns&I&have&even&when&he&or&she&does&not&ask& 2.72 3.03 3.25 3.73 3.28
7
I&am&confident&that&I&can&folow&through&on&medical&
&treatments&I&need&to&do&at&home& 2.76 2.99 3.18 3.78 3.27
8
I&understand&the&nature&and&causes&of&my&health&
condition(s)& 2.32 2.74 2.91 3.59 3.00
9
I&know&the&diferent&medical&treatment&options&
available&for&my&health&condition& 2.30 2.64 2.80 3.44 2.89
10
I&have&been&able&to&maintain&the&lifestyle&changes&for&
my&health&that&I&have&made& 2.02 2.38 2.76 3.19 2.70
11
I&know&how&to&prevent&further&problems&with&my&
health&condition& 2.34 2.81 2.92 3.51 3.00
12
I&am&confident&I&can&figure&out&solutions&when&new&
situations&or&problems&arise&with&my&health&condition& 2.19 2.59 2.85 3.39 2.86
13
I&am&confident&that&I&can&maintain&lifestyle&changes&
like&diet&and&exercise&even&during&times&of&stress& 1.98 2.34 2.72 3.26 2.70
PAM%Item%Number%and%Text
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Appendix Table 15: Distribution of PAM score, PAM Score Change from Last Survey, and Interval Between PAM Surveys by number of 









Participants Mean Median Mean Median Mean Median
1st 1041 100% 61.0 60.0 49.9 *70.8 *
2nd 915 88% 63.2 60.0 52.9 *73.1 2.5 2.2 *5.3*9.6 13622 98 90*154
3rd 760 73% 63.8 61.6 52.9 *75.3 0.5 0.0 *6.8*7.2 12022 97 89*134
4th 659 63% 65.5 63.2 52.9 *77.5 2.0 0.0 *5.3*9.0 10522 92 81*116
5th 298 29% 65.7 63.2 52.9 *77.5 *1.0 0.0 *8.2*6.0 10722 97 87*120
6th 158 15% 67.3 66.0 52.9 *80.0 1.6 0.0 *5.3*9.0 98222 93 81*106
7th 57 5% 67.6 66.0 52.9 *77.5 *3.1 0.0 *9.0*4.5 98222 93 86*109
8th 8 1% 70.6 69.6 56.4 *81.4 2.7 0.0 *2.2*7.4 89222 92 84*99










Appendix Table 16: Baseline Survey Instrument 
1. How wel does Kaiser Permanente take care of your healthcare needs?  
2. How wel does your personal physician understand your healthcare needs?  
3. Do you know whom to cal to obtain Kaiser Permanente services that you need? 
4. How accessible/available are Kaiser Permanente’s specialists when you need to meet with 
one (e.g., ophthalmologist, alergist, and neurologist, etc.)? 
5. Rate Kaiser Permanente’s ability to provide for your healthcare needs compared to other 
providers. 





Appendix Table 17: Distribution of Number of Hospitalizations During Folow-up Period 
Total	  #	  of	  
Hospitalizations	  
During	  Study	  
#	  of	  Participants	  with	  
Hospitalization	  total	  
%	  of	  Participants	   Cumulative	  %	  
0	   768	   74%	   74%	  
1	   163	   16%	   89%	  
2	   59	   6%	   95%	  
3	   21	   2%	   97%	  
4	   11	   1%	   98%	  
5	   4	   0%	   99%	  
6	   4	   0%	   99%	  
7	   5	   0%	   99%	  
8	   2	   0%	   100%	  
9	   0	   0%	   100%	  
10	   1	   0%	   100%	  
11	   1	   0%	   100%	  
12	   1	   0%	   100%	  
13	   0	   0%	   100%	  
14	   0	   0%	   100%	  
15	   0	   0%	   100%	  
16	   1	   0%	   100%	  
	  
1,041	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Appendix Table 18: Distribution of Number of Emergency Department visits During 
Folow-up Period (excluding three extreme observations with 75, 124, and 234 ED visits 
during folow-up) 
Total	  #	  of	  ED	  visits	   #	  of	  Participants	   %	  of	  Participants	   Cumulative	  %	  
0	   311	   30%	   30%	  
1	   210	   20%	   50%	  
2	   158	   15%	   65%	  
3	   107	   10%	   76%	  
4	   62	   6%	   82%	  
5	   48	   5%	   86%	  
6	   33	   3%	   89%	  
7	   24	   2%	   92%	  
8	   15	   1%	   93%	  
9	   12	   1%	   94%	  
10	   10	   1%	   95%	  
11	   5	   0%	   96%	  
12	   11	   1%	   97%	  
13	   6	   1%	   97%	  
14	   1	   0%	   98%	  
15	   5	   0%	   98%	  
16	   3	   0%	   98%	  
17	   6	   1%	   99%	  
18	   2	   0%	   99%	  
21	   3	   0%	   99%	  
22	   2	   0%	   100%	  
26	   1	   0%	   100%	  
28	   1	   0%	   100%	  
34	   1	   0%	   100%	  
44	   1	   0%	   100%	  
	   1,038	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Appendix Table 19: Intervention description, categorization, and frequency for members with multiple PAM surveys 
 
Code Description Type Count %
1Advance)Directive)Placed)in)onsite)medical)center)location Non4Coaching 2 0.0%
2Arranged/Utilized)authorized)Title)22)non4urgent)or)emergent)transportation Non4Coaching 10 0.0%
3Arranged/Atended)Clinic)visit)(routine)or)urgent) Non4Coaching 436 1.2%
4Arranged/Utilized)DME Non4Coaching 72 0.2%
5Arranged/Utilized)Language)Interpreter)Service Non4Coaching 71 0.2%
6Arranged/Utilized)non4urgent)or)emergent)transportation)services Non4Coaching 147 0.4%
7Arranged/Kept7meeting7(patient,7family/significant7other,7or7provider) NonACoaching 1079 3.1%
8Assistance)with)forms/apps)related)to)community,)financial,)or)legal)resources Non4Coaching 338 1.0%
9Atend)Member's)clinic)visit Non4Coaching 96 0.3%
10Contact)Board)&)Care)/)Assisted)Living)staf Non4Coaching 8 0.0%
11Contact)Chronic)Conditions)Program)staf Non4Coaching 97 0.3%
12Contact)Discharge)Planner Non4Coaching 18 0.1%
13Contact)DME)staf Non4Coaching 49 0.1%
15Contact)Home)Health)staf Non4Coaching 6 0.0%
16Contact)Hospital)Based)staf)(MD)and)Non)MD) Non4Coaching 48 0.1%
17Contact)Member)Services Non4Coaching 43 0.1%
18Contact)Paliative)Care)Services)staf Non4Coaching 2 0.0%
19Contact)Police,)Child)Protective)Services,)Adult)Protective)Services Non4Coaching 9 0.0%
20Contact)SNF)MD)or)RN Non4Coaching 9 0.0%
21Contact)Specialist)(MD)and)Non)MD) Non4Coaching 589 1.7%
22Contact7PCP NonACoaching 1712 4.8%
23Coordinated/Utilized)urgent)or)emergent)services)(e.g.)cal)911) Non4Coaching 45 0.1%
24Establish)appropriate)"Alerts")in)CIPS/Health)Connect Non4Coaching 333 0.9%
25Medication7reconciliation Coaching 1092 3.1%
26Provide7emotional7support Emotional 5426 15.4%
27Advance)Directive)discussed Coaching 97 0.3%
28Ambulance)benefit)and)appropriate)use)of)ambulance)service Coaching 14 0.0%
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Appendix Table 19 (Continued): Intervention description, categorization, and frequency for members with multiple PAM surveys 
 
Code Description Type Count %
29Benefit5Interpretation5(DME,5co<pay,5etc.) Coaching 1047 3.0%
30Educated5on/Accurately5Utilized5Diet/Nutrition/Exercise Coaching 1456 4.1%
31Educated*on/Accurately*Utilized:*Routine,*Urgent,*and*ED*Services Coaching 654 1.9%
32Educated*on/Accurately*Utilized*Health*Education*materials Coaching 638 1.8%
33Educated*on/Accurately*Utilized*Home*safety*(fal*prevention,*etc.) Coaching 351 1.0%
35Educated*on/Accurately*Accessed*Advice*Nurse/Cal*Center Coaching 643 1.8%
36Educated*on/Accurately*Utilized*KP.org*internet*access*and*usage Coaching 368 1.0%






39Referred*to/Atended*Alcoholics*Anonymous NonWCoaching 26 0.1%
40Referred*to/Atended*Narcotics*Anonymous NonWCoaching 11 0.0%
41Referred*to/Atended*Chemical*Dependency*Recovery*Program*(Kaiser) NonWCoaching 27 0.1%
42Referred*to/Atended*chemical*dependency*in*the*community NonWCoaching 17 0.0%
43Referred*to/Utilized*Mental*Health*Crisis*Line NonWCoaching 131 0.4%
44Referred*to/Atended*Mental*Health*department NonWCoaching 130 0.4%
45Referred5to/Utilized5PCP Non<Coaching 1162 3.3%
46Referred*to/Atended*Pharmacy*Medication*Education NonWCoaching 29 0.1%
47Referred*to/Utilized*Physician*Selection*services NonWCoaching 602 1.7%
48Referred*to/Atended*Chemical*Dependency*program*(Self*Referral) NonWCoaching 3 0.0%
49Referred*to/Atended*Substance*Abuse*program*(Self*Referral) NonWCoaching 5 0.0%
50Referred*to/Utilized*Mental*Health*or*Behavior*Medicine*Services NonWCoaching 425 1.2%
51Referral*to*Quality*Assurance*(QA)*program NonWCoaching 2 0.0%
52Referred*to/Utilized*Clin.*Health*Ed.*services*or*Health*Ed.*classes NonWCoaching 470 1.3%
53Referred*to/*Utilized*Dietician,*Nutritionist,*or*Weight*Mngmt. NonWCoaching 104 0.3%
54Referred*to/Atended*Disease*Management*program NonWCoaching 39 0.1%
55Referred*to/Atended*Health*Education*program NonWCoaching 99 0.3%
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Appendix Table 19 (Continued): Intervention description, categorization, and frequency for members with multiple PAM surveys 
 
Code Description Type Count %
56Referred(to/Received(Home(Health(Services Non8Coaching 2 0.0%











61Contact(Community(Resources Non8Coaching 213 0.6%






64Referred(to/Utilized(Dental(Care Non8Coaching 105 0.3%
65Referred(to/Utilized(Smoking(Cessation(Services Non8Coaching 109 0.3%
66Attempt5to5reach5Member Failed 5361 15.2%
67Confirm5Member5Appointment NonOCoaching 1913 5.4%
68Contact(Health(Education Non8Coaching 30 0.1%
69Referred(to/Utilized(Community(Resources(for(Food(Bank/Closets Non8Coaching 45 0.1%





















75Referred(to/Utilized(Community(Resources(for(Low(Income(Utilities Non8Coaching 19 0.1%
76Referred(to/Utilized(Community(Resources(for(Medi8Cal Non8Coaching 174 0.5%
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Appendix Table 19 (Continued): Intervention description, categorization, and frequency for members with multiple PAM surveys 
 
Note: The count is the total number of interventions or failed interventions between the first PAM survey and the last PAM survey for that 
member. Intervention is bolded if its total frequency is greater than or equal to 2% of the total. 
 
Code Description Type Count %
77Referred'to/Utilized'Community'Resources'for'Social'Security Non9Coaching 12 0.0%
78Referred'to/Utilized'Community'Resources'for'SSI'Supp.'Security'Inc. Non9Coaching 9 0.0%
79Referred'to/Utilized'Community'Resources'for'Support'Group Non9Coaching 51 0.1%
80Referred'to/Utilized'Community'Resources'for'Day'Activity'Programs Non9Coaching 12 0.0%
81Referred'to/Utilized'Community'Resources'for'Crisis'Nursery Non9Coaching 13 0.0%
82Referred'to/Utilized'Business'Ofice'Services'(Biling'Colection,'etc.) Non9Coaching 7 0.0%
83Contact'Mental'Health'staf'and/or'Chemical'Dependency'Staf Non9Coaching 61 0.2%
84Contact'Pharmacy'staf Non9Coaching 15 0.0%
85Contact'OB/Gyn Non9Coaching 86 0.2%
87Educated'on/Completed'Labs'or'Diagnostic'Tests Coaching 657 1.9%
88Educated4on/Accurately4verbalized4treatment4goals Coaching 1515 4.3%
90Referred'to/Utilized'Ob/Gyn Non9Coaching 106 0.3%
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Appendix Table 20: Distribution of interventions and failed interventions by intervention 
category and detailed type for patients with multiple PAM surveys 
 
Note:  
• The count is the total number of interventions or failed interventions between the first 
PAM survey and the last PAM survey for that member 






















Appendix Table 21: Mean Change in PAM Item Response (last survey minus first survey) by first PAM Level and Score Change Quartile 
 
Notes: Item response differences bolded if paired t-test p-value <= 0.05. Responses coded as 1=Disagree Strongly, 2=Disagree, 3=Agree, 
4=Agree Strongly. Missing responses to items not included in means. PAM score change quartiles based on a median (interquartile range) of the 
last minus first PAM score change of 2.8 (-4.8-12.6). 
ΔQ1ΔQ2ΔQ3ΔQ4 Al ΔQ1ΔQ2ΔQ3ΔQ4 Al ΔQ1ΔQ2ΔQ3ΔQ4 Al ΔQ1ΔQ2ΔQ3ΔQ4 Al
7 43 52 61163 23 46 46 67182 70 65 72 60267 122 87 48 46303915
1I,am,responsible 80.3 0.1 0.1 0.6 0.3 80.2 0.0 0.1 0.5 0.2 -0.4 0.0 0.1 0.4 0.0 -0.3 0.0 0.2 0.1-0.10.1
2Active,role,is,important 0.0 0.0 0.2 0.6 0.3 -0.380.180.1 0.5 0.1 -0.5 0.0 0.2 0.6 0.1 -0.3 0.0 0.1 0.380.1 0.1
3
Confident,can,minimize,
problems, 80.2-0.3 0.3 0.6 0.3 -0.380.1 0.2 0.6 0.2 -0.5 0.0 0.1 0.6 0.0 -0.6-0.2 0.2 0.3-0.20.0
4Know,what,medications, 80.1 0.0 0.3 0.6 0.3 -0.480.2 0.2 0.5 0.1 -0.580.1 0.3 0.6 0.1 -0.4 0.1 0.2 0.3-0.10.1
5
Confident,know,when,
need,care -0.9 0.0 0.3 0.7 0.3 -0.380.2 0.0 0.5 0.1 -0.580.1 0.3 0.7 0.1 -0.5 0.0 0.1 0.2-0.10.1
6
Confident,can,tel,provider,
concerns -1.3 0.0 0.2 0.7 0.3 -0.480.1 0.1 0.5 0.1 80.1 0.0 0.2 0.7 0.2 -0.4 0.0 0.1 0.480.1 0.1
7
Confident,can,folow,
through,on,treatments 80.6-0.3 0.2 0.6 0.2 -0.5 0.0 0.0 0.6 0.2 -0.2 0.0 0.2 0.8 0.2 -0.6 0.0 0.1 0.2-0.20.1
8
Understand,the,nature,of,
condition(s) 80.3 0.1 0.0 0.9 0.3 -0.480.1 0.2 0.6 0.2 -0.2 0.0 0.2 0.6 0.1 -0.580.1 0.1 0.3-0.20.1
9Know,treatment,options 0.0 0.0 0.3 0.6 0.3 80.2 0.2 0.0 0.7 0.3 80.1 0.0 0.2 0.8 0.2 -0.4 0.0 0.1 0.580.1 0.2
10
Able,to,maintain,lifestyle,
changes 0.1 0.0 0.3 1.1 0.5 80.2 0.1 0.5 0.9 0.5 -0.2 0.0 0.3 0.7 0.2 -0.4 0.0 0.4 0.8 0.1 0.3
11
Know,how,to,prevent,
further,problems 0.0 0.0 0.2 0.7 0.3 -0.580.2 0.2 0.5 0.1 -0.3 0.0 0.1 0.7 0.1 -0.680.1 0.0 0.5-0.20.1
12
Confident,can,solve,new,
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